Novel polymer and DNA copolymer coatings
Novel polymer coatings and grafted DNA copolymers optimize SBS processes by eliminating grafting inefficiencies, enhancing primer accessibility, and reducing side reactions, thereby improving the efficiency and consistency of nucleic acid sequencing.
Patent Information
- Application Number
- JP2022100473
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2014-10-31
- Filing Date
- 2022-06-22
- Publication Date
- 2024-11-21
- Estimated Expiration
- 2035-10-26
AI Technical Summary
Existing sequencing-by-synthesis (SBS) processes face challenges with high costs and quality control issues due to inherent inefficiencies in grafting polymers or hydrogels onto substrates, which affect primer accessibility and lead to side reactions.
Development of novel polymer coatings and grafted DNA copolymers that eliminate or minimize grafting processes, enhancing primer accessibility and reducing side reactions through optimized surface functionalization, using polymers with specific repeating units and covalent bonding methods.
The novel coatings improve the efficiency and consistency of nucleic acid sequencing by maximizing primer accessibility and minimizing side reactions, leading to improved quality control and reduced manufacturing variability.
Smart Images

Figure 0007588115000095 
Figure 0007588115000096 
Figure 0007588115000097
Abstract
Description
[Technical field]
[0001] [Incorporation by reference to priority application] The present invention relates to a method for the production of a medicament for the treatment of a brain tumor, the method comprising: The present application claims priority to U.S. Provisional Patent Application No. 62 / 073,764, filed on the 1st of this document. do.
[0002] Generally, this application relates to the fields of chemistry, biology, and materials science. The technology has been applied to functionalize substrate surfaces and to develop novel nanoparticles for applications such as DNA sequencing and other diagnostic applications. Novel polymer coatings and grafted DNA copolymers to support fluidics applications Methods for preparing such functionalized surfaces and their uses are also disclosed. [Background technology]
[0003] Substrates coated with polymers or hydrogels are used in many technical applications. For example, implantable medical devices can be coated with biologically inert polymers. In another example, a polymer or hydrogel coated The substrate is used for the preparation and / or analysis of biomolecules. Molecular analysis, such as ELISA, is performed on substrate surfaces coated with polymers or hydrogels. The sequence of the bound nucleic acid strand is then determined by methods well known in the art. This can be determined in several different ways.
[0004] In a sequencing-by-synthesis ("SBS") process, one of the flow cells Coating one or more surfaces with a polymer or hydrogel, which is then However, the coating is There are inherent costs associated with performing the coating, grafting, and quality control steps. Summary of the Invention
[0005] This application relates to SBS applications and to the application where the primer polymer binding step is an early A polymeric coating is disclosed that is useful in processes integrated into polymer synthesis. This is used to manufacture sequencing flow cells or other substrates used in SBS. It is possible to eliminate some or all of the grafting processes that take place. The sequence maximizes primer accessibility to downstream biochemistry, minimizes side reactions, and results in more efficient The coatings and processes disclosed herein can provide efficient surface chemistry. The enzymes may be used, but are not limited to, in the synthesis or detection of nucleic acids and other bioactive molecules. The present invention is useful in other analytical devices and processes, including those that are
[0006] Some embodiments described herein include a repeat unit of formula (I) and a repeat unit of formula (II) The present invention relates to polymers for surface functionalization, comprising moieties.
[0007] [ka]
[0008] In the formula, R 1a , R 2a , R 1b , and R 2b are each independently hydrogen, substituted alkyl or optionally substituted phenyl; R 3a and R 3b teeth , each independently being hydrogen, an optionally substituted alkyl, an optionally substituted phenyl, or or any substituted C 7~14 aralkyl; L 1 and L 2 are respectively Independently, an optionally substituted alkylene linker or an optionally substituted heteroalkylene linker. In some embodiments, the polymer is further selected from the group consisting of polyacrylamide. Polyacrylate, Polyurethane, Polysiloxane, Silicone, Polyacrolein , polyphosphazenes, polyisocyanates, polyols, and polysaccharides. The compound may include one or more repeat units selected from the group consisting of: In some such embodiments, the polymer further comprises a compound represented by formula (IIIa) or formula (IIIb): (IIIb) or both may contain one or more polyacrylamide repeat units. .
[0009] [ka]
[0010] In the formula, R 4a , R 4b , and R 5b are hydrogen or C 1~3 From alkyl Selected, R 5a , R 6a , R 6b , and R 7b are each independently hydrogen, optionally Replaced C 1~6 alkyl, or optionally substituted phenyl.
[0011] Some embodiments described herein include a repeating unit of formula (I) as described herein. and a substrate having a first surface comprising a polymer having a repeat unit of formula (II). In some embodiments, the polymer may further comprise one or more of the various different polymer backbones described above. Repeat units of formula (IIIa) or (IIIb), or both, It may include one or more positions.
[0012] In some embodiments, when the polymer is covalently attached to the first surface of the substrate, the repeating group of formula (II) At least one covalent bond is formed between the amino group of the unit and the first surface of the substrate. Therefore, as described herein, a compound having a repeat unit of formula (I) and a repeat unit of formula (II) is The substrate having a first surface to which a polymer having a covalent bond is also provided. Position, structure [ka] It should be understood to include polymers having modified repeat units of the formula:
[0013] Some embodiments described herein include a repeating unit of formula (I) as described herein. and a functionalized oligonucleotide covalently attached to a polymer having a repeating unit of formula (II) In some embodiments, the polymer further comprises the above-mentioned One or more repeat units of a variety of different polymer backbones such as those of formula (IIIa) or one or more repeat units of polyacrylamide of formula (IIIb) or both It may include a position.
[0014] In some embodiments, when the functionalized oligonucleotide is covalently attached to the polymer, it can be represented by the formula: As a result of the reaction between the azide group of the repeating unit of I) and the functionalized oligonucleotide, At least two covalent bonds are formed. Therefore, as described herein, The repeating unit and the functionalized oligonucleotide covalently attached to the polymer of the repeating unit of formula (II) The grafted polymers containing the amides have a structure indicating the location of the covalent bond with the functionalized oligonucleotide. ,structure [ka] [ka] It should be understood that polymers having modified repeating units of the formula:
[0015] Some embodiments described herein include a polymer for surface functionalization comprising a repeat unit of formula (IV): Concerning Rimmer.
[0016] [ka]
[0017] In the formula, R 1c and R 2c each independently represents hydrogen, optionally substituted alkyl, or optionally substituted phenyl; R 3C is hydrogen, optionally substituted alkoxy phenyl, optionally substituted phenyl, or optionally substituted C 7~14 Select from aralkyl Ar is optionally substituted C 6~10 Aryl, or an optionally substituted 5-membered or 6-membered heteroaryl; R A is an optionally substituted tetrazine, L 3 may be a single bond, an optionally substituted alkylene linker, or an optionally substituted heterocyclic In some embodiments, the polymer further comprises a polyalkylene linker. Acrylamide, polyacrylate, polyurethane, polysiloxane, silicone, polya Chlorine, polyphosphazenes, polyisocyanates, polyols, and polysaccharides or a combination thereof, In some such embodiments, the polymer may further comprise the structure shown above. Reaction of polyacrylamide of formula (IIIa) or (IIIb) or both of them It may contain one or more subunits.
[0018] Some embodiments described herein include repeating groups of formula (IV) as described herein. In some embodiments, the polymer comprises a first surface having a unit. The mer may further comprise a variety of different polymer backbone repeat units as described above, for example, a) or (IIIb) or both of the repeating units of polyacrylamide may include multiple.
[0019] In some embodiments, when the polymer is covalently attached to the first surface of the substrate, the repeating group of formula (IV) As a result of the reaction between the tetrazine groups of the units and the first surface of the substrate, at least two covalent In some other embodiments, a bond is formed between the tetrazine groups of the repeating units of formula (IV). At least two covalent bonds are formed in the aryl group. Therefore, as described herein, the formula ( A substrate having a first surface comprising a polymer having repeating units of IV) can also be used as described herein. So, the structure [ka] (In the formula, Ar-RAA The moiety indicates the location of a covalent bond to the substrate surface. [ka] is selected from [ka] R AA It should be understood to include polymers having modified repeat units of It is.
[0020] Some embodiments described herein include a repeating unit of formula (IV) as described herein. A grafted polymer comprising a functionalized oligonucleotide covalently attached to a polymer having a In some embodiments, the polymer may further comprise a variety of different polymers as described above. -skeleton repeating units, for example polycyclic aromatic hydrocarbons of formula (IIIa) or (IIIb) or both It may contain one or more repeating units of acrylamide.
[0021] In some embodiments, when the functionalized oligonucleotide is covalently attached to the polymer, it has the formula (I As a result of the reaction between the tetrazine groups of the repeating units of V) and the functionalized oligonucleotides, At least two covalent bonds are formed. Therefore, as described herein, the formula (I V) Grafted polymers containing functionalized oligonucleotides covalently bonded to the repeating unit of the polymer. Rimar has the structure [ka] (In the formula, Ar-R AB The moiety indicates the position of covalent attachment to the oligonucleotide, [ka] is selected from [ka] R AB It is understood that polymers having modified repeat units of the formula: I want to be.
[0022] Some embodiments described herein include a surface functionalization compound comprising a repeating unit of formula (V): Concerning polymers.
[0023] [ka]
[0024] In the formula, R 1d and R 2d each independently represents hydrogen, optionally substituted alkyl, or optionally substituted phenyl; R 3d are hydrogen, optionally substituted optionally substituted alkyl, optionally substituted phenyl, or optionally substituted C 7~14 Aral Selected from Kill, R B is an azide, an optionally substituted amino, a Boc-protected amino, a hydride, alkoxy, thiol, alkynyl, alkenyl, halo, epoxy, tetrazinyl, or a L 4 and L 5 each independently represents an optionally substituted alkyl group; and optionally substituted heteroalkylene linkers. In embodiments, the polymer further comprises a compound represented by Formula (VIa) or Formula (VIb), or both It may contain repeating units.
[0025] [ka]
[0026] In the formula, R 1e , R 2e , R 1f , and R 2f are each independently hydrogen, In some embodiments, the aryl group is selected from the group consisting of substituted alkyl, optionally substituted alkyl, and optionally substituted phenyl. The polymers are further classified as polyacrylamides, polyacrylates, polyurethanes, polysilanes, etc. Roxane, silicone, polyacrolein, polyphosphazene, polyisocyanate, poly repeating units selected from the group consisting of saccharides, oligosaccharides, and polysaccharides, or their It may include one or more combinations.
[0027] Some embodiments described herein include a repeat unit of formula (V) as described herein. In some embodiments, the polymer may further comprise repeat units of formula (VIa) or formula (VIb), or both. In some embodiments, the polymer further comprises one or more repeat units of the various different polymer backbones described above. It may include one or more.
[0028] In some embodiments, the polymer comprises a repeating unit of formula (V) when covalently attached to the first surface of the substrate. At least two covalent bonds are formed as a result of the reaction between the azide groups at the positions and the first surface of the substrate. Thus, as described herein, a polymer having a repeat unit of formula (V) The substrate having a first surface to which is covalently attached also has the structure [ka] It is to be understood that the term includes polymers having modified repeat units of the formula:
[0029] In some other embodiments, when the polymer is covalently attached to the first surface of the substrate, the polymer has a reaction of formula (V) At least one covalent bond is formed between the amino group of the repeating unit and the first surface of the substrate. Therefore, as described herein, a polymer having a repeat unit of formula (V) is covalently attached The substrate having the first surface also has a structure indicating the location of a covalent bond to the substrate surface. [ka] It is to be understood that the term includes polymers having modified repeat units of the formula:
[0030] Some embodiments described herein include a repeat unit of formula (V) as described herein. A grafted polymer comprising a functionalized oligonucleotide covalently attached to a polymer having In some embodiments, the polymer further comprises a compound represented by formula (VIa) or formula (VIb): In some embodiments, the polymer may further comprise the repeating units of It may contain one or more repeat units of a variety of different polymer backbones.
[0031] In some embodiments, when the functionalized oligonucleotide is covalently attached to the polymer, it has the formula (V As a result of the reaction between the epoxy groups of the repeating units of Ia) and the functionalized oligonucleotides, At least one covalent bond is formed. Therefore, as described herein, A functionalized oligonucleotide covalently bonded to a polymer of repeating units of formula (VIa) The grafted polymer containing the leucine also has a site for covalent attachment to the oligonucleotide. Show, structure [ka] It is to be understood that polymers having modified repeating units of the formula:
[0032] Some embodiments described herein include a method for fixing a grafted polymer to a first surface of a substrate. Regarding the process, the process comprises: providing a substrate having a first surface having a first plurality of functional groups covalently attached thereto; A grafted polymer comprising a functionalized oligonucleotide covalently attached to the polymer. providing a grafted polymer, said polymer comprising a second plurality of functional groups; , reacting a first plurality of functional groups on the first surface with a second plurality of functional groups on the polymer; thereby covalently bonding the polymer to the first surface of the substrate.
[0033] In some embodiments of the methods described herein, the cycloalkene, cycloalkyne, A functionalized cycloalkylene compound containing an unsaturated moiety selected from heterocycloalkenes and heterocycloalkynes. The surface was treated with lanthanide, and the functionalized oligonucleotide was attached to bicyclo[6.1.0]non-4-isocyanate. When the polymer contains [ka] (In the formula, n is an integer ranging from 1 to 20,000, and m is an integer ranging from 1 to 100,000. Poly(N-(5-azidoacetamidylpentyl)acrylamide-co-acrylamide) In some such embodiments, the functionalized silane is not polyaryl amide (PAZAM). The unsaturated portion includes norbornene.
[0034] Some embodiments described herein include providing a polymer described herein on a first surface of a substrate. The present invention relates to a process or method for immobilizing a first plurality of functional groups covalently bonded to the first substrate, comprising: Providing a substrate having a surface; providing a polymer as described herein; reacting a first plurality of functional groups on the first surface with the polymer, thereby forming a polymer and covalently bonding a cationically linked ligand to the first surface of the substrate. [Brief description of the drawings]
[0035] [Figure 1A] FIG. 13 shows a Typhoon fluorescence image of a polymer-coated flow cell with a norbornene silane monolayer surface. [Figure 1B] FIG. 1 shows a related bar graph of the median Typhoon strengths of the polymers of Example 1 (Table 2). [Figure 1C] FIG. 13 shows a Typhoon fluorescence image of a polymer-coated flow cell with a norbornene silane monolayer surface. [Figure 1D] FIG. 1 shows a related bar graph of the median Typhoon strengths of the polymers of Example 1 (Table 2). [Figure 2A] FIG. 13 shows a Typhoon fluorescence image of a polymer-coated flow cell with a norbornene silane monolayer surface. [Figure 2B] FIG. 1 shows a related bar graph of the median Typhoon strengths of the polymers of Example 1 (Table 3). [Figure 2C] FIG. 13 shows a Typhoon fluorescence image of a polymer-coated flow cell with a norbornene silane monolayer surface. [Figure 2D] FIG. 1 shows a related bar graph of the median Typhoon strengths of the polymers of Example 1 (Table 3). [Figure 3A] FIG. 1 shows line and bar graphs illustrating TET QC strength data (Table 4) after coating a norbornene surface with various polymers (Table 2) listed in Example 1, and the percent surface reduction measured after thermal stress testing. [Figure 3B]FIG. 1 shows line and bar graphs showing TET QC strength data (Table 5) after coating an epoxy surface with various polymers listed in Example 1 (Table 3) and the percent surface reduction measured after thermal stress testing. [Figure 4A] FIG. 13 shows a Typhoon fluorescence image of a polymer-coated flow cell with a norbornene silane monolayer surface. [Figure 4B] FIG. 1 shows a related bar graph of the median Typhoon strengths of the polymers of Example 1 (Table 6). [Figure 4C] FIG. 13 shows a Typhoon fluorescence image of a polymer-coated flow cell with a norbornene silane monolayer surface. [Figure 4D] FIG. 1 shows a related bar graph of the median Typhoon strengths of the polymers of Example 1 (Table 6). [Figure 4E] FIG. 1 shows line and bar graphs illustrating TET QC strength data (Table 7) after coating a norbornene surface with various polymers listed in Example 1 (Table 6) and the percent surface reduction measured after thermal stress testing. [Diagram 5] FIG. 2 shows a series of NMR images of the reaction between norbornene and bipyridyltetrazine at different time points. [Figure 6] FIG. 1 shows a line graph of the UV-Vis absorption pattern of the reaction between bipyridine tetrazine and bicyclo[6.1.0]non-4-yn-9-ylmethanol. [Figure 7] FIG. 1 shows the coupling reaction between a grafted dendrimer and a functionalized dendrimer bearing surface binding groups. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0036] This application relates to nucleic acid copolymers (e.g., DNA copolymers) and to methods for preparing such nucleic acid copolymers. The present invention relates to a process for grafting single stranded DNA ("ssDNA") to the surface of a substrate. ") for pre-conjugation with the primer Some embodiments of the polymer used in the present invention include acrylamide / azido-acrylamide. / Aminoethyl-acrylamide ternary copolymer, tetrazine modified polyacrylamide, and poly(glycidyl methacrylate) with amino-PEG-azide or amino- The nucleic acid copolymer is then coated onto the surface of the substrate. In some cases, silane functional groups on a substrate, such as the surface of a flow cell or the surface of a molecular array, are The present disclosure also relates to such nucleic acid-copolymers that can be covalently attached to functionalized surfaces. - Method for preparing coated surfaces and such nucleic acid-copolymer coatings - Patents.com The present invention relates to a method for using a substrate comprising a surface in a sequencing-by-synthesis reaction.
[0037] Some embodiments include bicyclo[6.1.0]non-4-ynes, alkynes, amides, or The polymers described herein may be linked via one or more functional groups, such as an azide-derivatized linkage. A sequencing batch containing functionalized oligonucleotides pre-conjugated to a primer. In some embodiments, the primers are is a P5 primer or a P7 primer. P5 primer and P7 primer HiSeq (registered trademark), MiSeq (registered trademark), NextSeq (registered trademark), and Genome Analyzer® platform sequencing The surface of a commercially available flow cell sold by Illumina for ionization was used. do.
[0038] By incorporating quality control (QC) markers into the polymer along with the primer binding, Further process and cost savings can be achieved. Using analytical testing, QC markers and The quality and consistency of the DNA copolymers can be determined by repeating the analysis test. This can be used to determine the effectiveness of the deposition when working with the open wafer format. These additional quality control checkpoints allow batches to be produced that yield a more consistent product. This reduces flow cell batch variation to a minimum. When a fault occurs during manufacturing, where is the process deviation? This should help narrow down what may have happened.
[0039] definition Unless otherwise defined, all technical and scientific terms used herein are understood to be within the skill of the art. The use of the term "including" has the same meaning as it is more commonly understood. The terms "include", "includes", and "included" are used. The term "included" is not limiting, as are other forms such as "included." The use of "have", "has", and "had" As used herein, transitional phrases include "(had)" and "(had)." The terms "comprise(s)" and "comprise(s)" whether in the body of a claim "purising" should be construed as having an open-ended meaning. That is, the above term is intended to include the phrase "having at least east" or "including at least" For example, when used in the context of a process, the term "includes "comprising" means that the process includes at least the recited steps, When used in the context of a compound, composition, or device, the term "compound" means that the compound may include additional steps. When referring to a compound, composition, or device, the term "comprising" means that the compound, composition, or device Contains at least the features or components recited, but with additional features or configurations. This means that it may also contain elements.
[0040] As used herein, common organism abbreviations are defined as follows: Ac Acetyl Ac2O Acetic anhydride APTS Aminopropylsilane APTES (3-aminopropyl)triethoxysilane APTMS (3-aminopropyl)trimethoxysilane aq. Water-based ATRP Atom Transfer Radical Polymerization Azapa N-(5-azidoacetamidylpentyl)acrylamide BCN Bicyclo[6.1.0]nona-4-yne Bn Benzyl Brapa or BRAPA N-(5-bromoacetamidylpentyl)acrylamides D Bz Benzoyl BOC or Boc tert-butoxycarbonyl Bu n-Butyl Cat. Catalyst CMP chemical mechanical polishing CRP Controlled Radical Polymerization CVD Chemical Vapor Deposition °C degree Celsius temperature dATP deoxyadenosine triphosphate dCTP deoxycytidine triphosphate dGTP Deoxyguanosine triphosphate dTTP deoxythymidine triphosphate DCA Dichloroacetic acid DCE 1,2-dichloroethane DCM Methylene chloride DIEA Diisopropylethylamine DIPEA Diisopropylethylamine DMA Dimethylacetamide DME Dimethoxyethane DMF N,N'-Dimethylformamide DMSO Dimethyl sulfoxide DPPA Diphenylphosphoryl azide Et Ethyl EtOAc or EA Ethyl Acetate g grams h or hr Time iPr Isopropyl KPi 10 mM potassium phosphate buffer, pH 7.0 KPS Potassium peroxodisulfate IPA Isopropyl Alcohol IPHA.HCl N-Isopropylhydroxylamine Hydrochloride m or min MeOH Methanol MeCN Acetonitrile mL Milliliters NaN3 Sodium Azide NHS N-hydroxysuccinimide NMP Nitroxide-Mediated Radical Polymerization PAZAM Poly(N-) with any acrylamide to azapa ratio (5-Azidoacetamidylpentyl)acrylamide-co-acrylamide) PEG Polyethylene glycol PG protecting group PGMA Poly(glycidyl methacrylate) Ph Phenyl ppt precipitate RAFT Reversible Addition-Fragmentation Chain Transfer Polymerization rt room temperature SFA as defined in U.S. Patent Application Publication No. 2011 / 0059865 Silane-free acrylamide Sulfo-HSAB or SHSAB N-hydroxysulfosuccinimidyl-4- Azidobenoate TEA Triethylamine Tert, t third THF Tetrahydrofuran TEMED Tetramethylethylenediamine YES Yield Engineering Systems μL microliter
[0041] As used herein, the term "array" refers to a system in which different probe molecules are arranged in a matrix according to their relative positions. A collection of different probe molecules bound to one or more substrates such that they are distinguishable from one another. An array may contain different probe molecules, which are addressable on a substrate. Alternatively, or in addition, the array may include different probe molecules. Each of the probe molecules may comprise a separate substrate carrying the probe molecules, Depending on the position of the substrate on the bonding surface or depending on the position of the substrate in the liquid Exemplary arrays having separate substrates located on the surface include Although not limited to the above, for example, U.S. Pat. No. 6,355,431 and U.S. Pat. The present invention relates to a method for producing a medicament for the treatment of a disease, which is described in WO 2002 / 0102578 and WO 00 / 63437. For example, a fluorescence activated cell sorter (FASC) is used. In order to identify beads in a liquid array using a microfluidic device such as a CS, Exemplary formats that may be used in the art are described, for example, in U.S. Pat. No. 6,524,793. Further examples of arrays that can be used in the present invention include Although not limited thereto, U.S. Patent Nos. 5,429,807 and 5,436,327 disclose Specifications, Specification No. 5561071, Specification No. 5583211, No. 5658734 Specification of No. 5837858, Specification of No. 5874219, No. 59195 Specification No. 23, Specification No. 6136269, Specification No. 6287768, Specification No. 628 Specification No. 7776, Specification No. 6288220, Specification No. 6297006, Specification No. 6 Specification No. 291193, Specification No. 6346413, Specification No. 6416949, Specification No. 6416949, Specification No. Specification No. 6482591, Specification No. 6514751, Specification No. 6610482 , International Publication Nos. 93 / 17126, 95 / 11995, and 95 / 35505, The same as those described in European Patent Nos. 742287 and 799897 The following are some of the reasons.
[0042] As used herein, the term "covalently attached" means "Covalently bonded" or "covalently bonded" means This refers to the formation of a chemical bond characterized by the sharing of electron pairs between molecules. The polymer coating may also be attached to the surface by other means, such as adhesion or electrostatic interactions. Refers to a polymer coating that forms a chemical bond with the functionalized surface of a substrate, as opposed to bonding. It has been found that polymers that are covalently attached to a surface can also be attached via means other than covalent bonds. Let it be understood.
[0043] As used herein, "C a ~C b " or "C a ~b " refers to the number of carbon atoms in a particular group. That is, the group includes "a" to "b" (a and b) may contain carbon atoms. Thus, for example, a "C1-C4 alkyl" group Or a "C1-C4 alkyl" group refers to an alkyl group having 1 to 4 carbons, i.e., CH 3-, CH3CH2-, CH3CH2CH2-, (CH3)2CH-, CH3CH2CH 2CH2-, CH3CH2CH(CH3)-, and (CH3)3C-.
[0044] The terms "halogen" or "halo" as used herein refer to fluorine, chlorine, bromine and Some of the radio-stable atoms in the seventh column of the periodic table, such as iodine and iodine, It means any one of them, with fluorine and chlorine being preferred.
[0045] As used herein, "alkyl" refers to an alkyl group that is fully saturated (i.e., has no double or triple bonds). An alkyl group is a straight or branched hydrocarbon chain that has 1 to 20 carbon atoms. (Whenever appearing in this specification, numerical ranges such as "1 to 20" are within the given range. For example, "1 to 20 carbon atoms" means that the alkyl group has one carbon atom, means that it may consist of up to 20 carbon atoms, such as 2 carbon atoms, 3 carbon atoms, etc. However, this definition also encompasses occurrences of the term "alkyl" where no numerical range is specified. The alkyl group may also be a medium alkyl group having 1 to 9 carbon atoms. The group may also be a lower alkyl having 1 to 4 carbon atoms. ~4For purposes of example only, "C alkyl" or a similar designation may be used. 1~4 Al "Alkyl" means that there are 1 to 4 carbon atoms in the alkyl chain, i.e., the alkyl chain is a methyl group. Chill, ethyl, propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl Exemplary alkyl groups include those selected from the group consisting of butyl, tert-butyl, and t-butyl. , including but not limited to methyl, ethyl, propyl, isopropyl, butyl, isobutyl, Examples of alkyl groups include tert-butyl, pentyl, and hexyl. The alkyl groups are optionally substituted. obtain.
[0046] As used herein, "alkoxy" refers to the formula -OR, where R is an alkyl group such as "C 1~9 a and the like, including, but not limited to, methoxy, ethoxy ... ethoxy, n-propoxy, 1-methylethoxy (isopropoxy), n-butoxy, iso -butoxy, sec-butoxy, and tert-butoxy. Groups can be optionally substituted.
[0047] As used herein, "alkenyl" refers to a straight-chain or alkoxy group containing one or more double bonds. refers to a branched hydrocarbon chain. Alkenyl groups can have from 2 to 20 carbon atoms, but However, this definition also encompasses the occurrences of the term "alkenyl" where no numerical range is specified. The alkenyl group may also be a medium alkenyl having 2 to 9 carbon atoms. The alkenyl group may also be a lower alkenyl having 2 to 4 carbon atoms. "C 2~4 Alkenyl" or similar designations. For purposes of example only, "C ~4"Alkenyl" means that there are 2 to 4 carbon atoms in the alkenyl chain, i.e., The alkenyl chain is ethenyl, propen-1-yl, propen-2-yl, or propen-3-yl. , buten-1-yl, buten-2-yl, buten-3-yl, buten-4-yl, 1-methyl 2-ethyl-propen-1-yl, 2-methyl-propen-1-yl, 1-ethyl-ethen-1 -yl, 2-methyl-propen-3-yl, buta-1,3-dienyl, buta-1,2,- and buta-1,2-dien-4-yl. Exemplary alkenyl groups include, but are not limited to, ethenyl, propenyl, butenyl. , pentenyl, and hexenyl, etc. Alkyl groups can be optionally substituted.
[0048] As used herein, "alkynyl" refers to a straight-chain or alkynyl group containing one or more triple bonds. refers to a branched hydrocarbon chain. Alkenyl groups can have from 2 to 20 carbon atoms, but However, this definition also encompasses the occurrence of the term "alkynyl" when no numerical range is specified. The alkynyl group may also be a medium alkynyl having 2 to 9 carbon atoms. The alkynyl group may also be a lower alkynyl having 2 to 4 carbon atoms. "C 2~4 For purposes of example only, "C2 ~4 "Alkynyl" means that there are 2 to 4 carbon atoms in the alkynyl chain, i.e., The alkyl chain is ethynyl, propyn-1-yl, propyn-2-yl, butyn-1-yl, butyn-3-yl, butyn-4-yl, and 2-butynyl. Exemplary alkynyl groups include, but are not limited to, ethynyl, propynyl, Alkynyl groups include butynyl, pentynyl, and hexynyl. Alkynyl groups are optionally substituted. It can be done.
[0049] As used herein, "heteroalkyl" refers to a group containing one or more heteroatoms, i.e. , which contain elements other than carbon in the backbone, including, but not limited to, nitrogen, oxygen, and sulfur. Heteroalkyl groups are straight or branched hydrocarbon chains that contain 1 to 20 carbon atoms. However, this definition does not include the term "heteroalkyl" which does not specify a numerical range. Heteroalkyl groups also include intermediate heteroalkyl groups having 1 to 9 carbon atoms. Heteroalkyl groups can also be lower heteroalkyl groups having 1 to 4 carbon atoms. The heteroalkyl group can be "C 1~4 "Heteroalkyl" or a similar name A heteroalkyl group may contain one or more heteroatoms. As a target, "C 1~4 Heteroalkyl" means a heteroalkyl group having 1 to 4 carbon atoms in the heteroalkyl chain. indicates that there are, in addition, one or more heteroatoms present in the backbone.
[0050] As used herein, "alkylene" refers to an alkyl group that is attached to the rest of the molecule through two points of attachment. A branched or straight chain, fully saturated diradical chemical group containing only carbon and hydrogen (i.e., The alkylene group may have 1 to 20,000 carbon atoms. However, this definition also encompasses occurrences of the term alkylene where no numerical range is specified. The alkylene group may also be a medium alkylene having 1 to 9 carbon atoms. The alkylene group may also be a lower alkylene having 1 to 4 carbon atoms. C 1~4For purposes of example only, "C 1~ "4 alkylene" means that there are 1 to 4 carbon atoms in the alkylene chain, i.e., The alkylene chains are methylene, ethylene, ethane-1,1-diyl, propylene, and propane-1 ,1-diyl, propane-2,2-diyl, 1-methyl-ethylene, butylene, butane- 1,1-diyl, butane-2,2-diyl, 2-methyl-propane-1,1-diyl, 1 -Methyl-propylene, 2-methyl-propylene, 1,1-dimethyl-ethylene, 1,2 -dimethyl-ethylene, and 1-ethyl-ethylene. vinegar.
[0051] As used herein, the term "heteroalkylene" refers to one or more alkylene radicals. The backbone atoms are atoms other than carbon, such as oxygen, nitrogen, sulfur, phosphorus, or combinations thereof. The length of the heteroalkylene chain is 2 to 20,000. Exemplary heteroalkylenes include, but are not limited to, -OCH2- , -OCH(CH3)-, -OC(CH3)2-, -OCH2CH2-, -CH(CH3 )O-, -CH2OCH2-, -CH2OCH2CH2-, -SCH2-, -SCH(C H3)-, -SC(CH3)2-, -SCH2CH2-, -CH2SCH2CH2-, - NHCH2-, -NHCH(CH3)-, -NHC(CH3)2-, -NHCH2CH2 -, -CH2NHCH2-, and -CH2NHCH2CH2-.
[0052] As used herein, "alkenylene" refers to an alkyl group that contains only carbon and hydrogen and has two bonds. A straight-chain or means a branched diradical chemical group. The alkenylene group has 2 to 20,000 carbon atoms. However, this definition also applies to the term alkenyl when no numerical range is specified. The alkenylene group also includes the occurrence of alkenylene. The alkenylene group also includes the occurrence of intermediate alkenylene having 2 to 9 carbon atoms. An alkenylene group can also be a lower alkenylene having 2 to 4 carbon atoms. The alkenylene group can be "C 2~4 alkenylene" or a similar name For illustrative purposes only, 2~4 "Alkenylene" means that the alkenylene chain has 2 to 4 carbon atoms, i.e., the alkenylene chain is ethenylene, ethene-1,1- Diyl, Propenylene, Propene-1,1-diyl, Prop-2-ene-1,1-diyl , 1-methyl-ethenylene, but-1-enylene, but-2-enylene, but-1,3- Dienylene, butene-1,1-diyl, buta-1,3-diene-1,1-diyl, buta- 2-ene-1,1-diyl, but-3-ene-1,1-diyl, 1-methyl-prop-2 -ene-1,1-diyl, 2-methyl-prop-2-ene-1,1-diyl, 1-ethyl -Ethenylene, 1,2-dimethyl-ethenylene, 1-methyl-propenylene, 2-methyl -propenylene, 3-methyl-propenylene, 2-methyl-propene-1,1-diyl, and 2,2-dimethyl-ethene-1,1-diyl. .
[0053] As used herein, "alkynylene" refers to an alkynylene group that contains only carbon and hydrogen and has two bonds. A straight-chain or means a branched diradical chemical group.
[0054] The term "aromatic" refers to a ring or ring system having a conjugated pi-electron system, including carbocyclic aromatic rings. These include both aromatic (e.g., phenyl) and heteroaromatic (e.g., pyridine) groups. The term includes monocyclic groups or fused ring polycyclic groups, provided that all ring systems are aromatic. (i.e. rings which share adjacent pairs of atoms) groups are included.
[0055] As used herein, "aryl" refers to a ring structure having a ring backbone that is Aromatic rings or ring systems containing only carbon (i.e., two or more rings sharing two adjacent carbon atoms) When aryl is a ring system, all rings in the system are aromatic. The alkyl group may have from 6 to 18 carbon atoms, although this definition also includes any numerical ranges specified. In some embodiments, the term "aryl" also encompasses occurrences of the term "aryl" when not included. has 6 to 10 carbon atoms. An aryl group is defined as "C 6~10 Aryl, C6 or is C 10 Examples of aryl groups include, but are not limited to, Examples include, but are not limited to, phenyl, naphthyl, azulenyl, and anthracenyl. Aryl groups can be optionally substituted.
[0056] As used herein, an "allylene" is an allyl group that is attached to the rest of the molecule through two points of attachment. refers to an aromatic ring or ring system containing only carbon and hydrogen.
[0057] "Aralkyl" or "arylalkyl" means "C 7~14 Aralkyl" and other An aryl group linked as a substituent via an alkylene group, but is not limited thereto. However, benzyl, 2-phenylethyl, 3-phenylpropyl, and naphthyl alkyl In some cases, the alkylene group is a lower alkylene group (i.e., 1~4 Alki The aryl group.
[0058] As used herein, "heteroaryl" refers to a group containing one or more heteroatoms, i.e. , and elements other than carbon, including but not limited to nitrogen, oxygen, and sulfur, within the ring structure. Contains an aromatic ring or ring system (i.e., two or more fused rings sharing two adjacent atoms) When heteroaryl is a ring system, all rings in the system are aromatic. The ring group has 5 to 18 ring members (i.e., carbon atoms and heterocyclic groups). The number of atoms constituting the ring skeleton, such as atoms, may be any number, but this definition also includes numerical ranges. This also encompasses occurrences of the term "heteroaryl" when no range is specified. In the heteroaryl group, the heteroaryl group has 5 to 10 ring members or 5 to 7 ring members. is referred to as "5- to 7-membered heteroaryl", "5- to 10-membered heteroaryl", or a similar name. Examples of heteroaryl rings include, but are not limited to, furyl, thienoyl, and the like. Nyl, phthalazinyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl , isoxazolyl, isothiazolyl, triazolyl, thiadiazolyl, pyridinyl, pyridinyl ridazinyl, pyrimidinyl, pyrazinyl, triazinyl, quinolinyl, isoquinrinyl, Benzimidazolyl, benzoxazolyl, benzothiazolyl, indolyl, isoindo Heteroaryl groups can be optionally substituted, and examples of heteroaryl include aryl, aryl, and benzothienyl.
[0059] As used herein, a "heteroarylene" refers to a heteroaryl group that is attached to the rest of the molecule through two points of attachment. refers to an aromatic ring or ring system that contains one or more heteroatoms within the ring backbone, to which it is attached.
[0060] A "heteroaralkyl" or "heteroarylalkyl" is a heteroaryl group substituted with an alkylene group. Examples include, but are not limited to, heteroaryl groups linked as substituents. However, 2-thienylmethyl, 3-thienylmethyl, furylmethyl, thienylethyl, pyrrolidinyl Arylalkyl, pyridylalkyl, isoxazolylalkyl, and imidazolylalkyl In some cases, the alkylene group may be a lower alkylene group (i.e., 1~4 alkylene group).
[0061] As used herein, "carbocyclyl" refers to a ring system skeleton. A non-aromatic cyclic ring or ring system containing only carbon atoms within the ring When a carbocyclyl is a ring system, two or more of the rings may be fused, bridged, or The carbocyclyl may be attached in a spiro-connected manner. The ring system may be of any degree of saturation, provided that at least one ring within the ring system is not aromatic. Thus, carbocyclyl includes cycloalkyl, cycloalkenyl, and cycloa The carbocyclyl group may have 3 to 20 carbon atoms, provided that: This definition also encompasses occurrences of the term "carbocyclyl" when no numerical range is specified. A carbocyclyl group can also be one having 3, 4, 5, 6, 7, 8, 9, or 10 carbon atoms. The carbocyclyl group may also be a medium-sized carbocyclyl having 3 to 6 carbon atoms. The carbocyclyl group may be a carbocyclyl having a carbon atom. 3~6 Carbocyclyl " or similar names. Examples of carbocyclyl rings include, but are not limited to, However, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and cyclohexyl 2,3-dihydro-indene, bicyclo[2.2.2]octanyl, adamantyl and spiro[4.4]nonanyl.
[0062] As used herein, "cycloalkyl" refers to a fully saturated carbocyclyl ring or Examples include cyclopropyl, cyclobutyl, cyclopentyl, and Cyclohexyl is an example.
[0063] As used herein, a "cycloalkylene" refers to a group that is attached to the rest of the molecule through two points of attachment. "Carbocyclyl ring" refers to the fully saturated carbocyclyl ring or ring system to which the ring is attached.
[0064] As used herein, a "cycloalkenyl" or "cycloalkene" refers to at least one a carbocyclyl ring or means a ring system. An example is cyclohexenyl or cyclohexene. Another example is norbornyl. It is either norbornenyl or norbornenyl.
[0065] As used herein, "heterocycloalkenyl" or "heterocycloalkene" has at least one heteroatom in the ring skeleton and at least one double bond; Some embodiments refer to a carbocyclyl ring or ring system in which none of the rings in the ring system are aromatic. In embodiments, the heterocycloalkenyl or heterocycloalkene ring or ring system is 3 The aryl group may be 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 members.
[0066] As used herein, a "cycloalkynyl" or "cycloalkyne" refers to at least one a carbocyclyl ring or An example is cyclooctyne. Another example is bicyclononyne.
[0067] As used herein, "heterocycloalkynyl" or "heterocycloalkyne" has at least one heteroatom in the ring skeleton and at least one triple bond; It is intended to mean a carbocyclyl ring or ring system, none of the rings in the ring system being aromatic. In embodiments, the heterocycloalkynyl or heterocycloalkyne ring or ring system is 3 The aryl group may be 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 members.
[0068] As used herein, a "heterocyclyl" refers to a ring system that includes at least one heteroatom in the ring backbone. Heterocyclyl means a non-aromatic ring or ring system, including fused, bridged, or unfused rings or ring systems. The carbocyclyl may be attached in a spiro or spiro-linked manner. Heteroatoms may be at any degree of saturation, provided that they are not aromatic. The heterocyclyl group may be either an aromatic or aromatic ring. That is, the number of atoms constituting the ring structure, such as carbon atoms and heteroatoms, may be However, this definition also applies to the occurrence of the term "heterocyclyl" when no numerical range is specified. The heterocyclyl group also includes medium-sized heterocyclyl having 3 to 10 ring members. The heterocyclyl group may also be a heterocyclyl having 3 to 6 ring members. A heterocyclyl group may also be referred to as a "3- to 6-membered heterocyclyl" or similar designations. In a 6-membered monocyclic heterocyclyl, the heteroatoms are selected from 1 to 3 O, N, or S. In preferred 5-membered monocyclic heterocyclyls, the heteroatoms are selected from O, N, or S. 1 or 2 heteroatoms. Examples of heterocyclyl rings are limited to Not all are azepinyl, acridinyl, carbazolyl, cinnolinyl, dioxola nyl, imidazolinyl, imidazolidinyl, morpholinyl, oxiranyl, oxepanyl , thiepanyl, piperidinyl, piperadonyl, dioxopiperazinyl, pyrrolidinyl, rolidinyl, pyrrolidionyl, 4-piperidonyl, pyrazolinyl, pyrazolidinyl, 1, 3-dioxinyl, 1,3-dioxanyl, 1,4-dioxinyl, 1,4-dioxanyl 1,3-oxathiyl, 1,4-oxathiinyl, 1,4-oxathiyl, 2H -1,2-oxazinyl, trioxanyl, hexahydro-1,3,5-triazinyl, 1,3-dioxolyl, 1,3-dioxolanyl, 1,3-dithiolyl, 1,3-dithio aryl, isoxazolinyl, isoxazolidinyl, oxazolinyl, oxazolidinyl oxazolidinonyl, thiazolinyl, thiazolidinyl, 1,3-oxathiolanyl, Indolinyl, isoindolinyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydropyranyl Tetrahydrothiophenyl, tetrahydrothiopyranyl, tetrahydro-1,4-thiazinyl , thiamorpholinyl, dihydrobenzofuranyl, benzimidazolidinyl, and tetrahydrobenzoyl. Hydroquinoline is an example.
[0069] As used herein, a "heterocyclylene" is a heterocyclic ring that is attached to the rest of the molecule through two points of attachment. means a non-aromatic ring or ring system containing at least one heteroatom to which is bonded.
[0070] As used herein, "acyl" refers to -C(=O)R, where R is an acyl group as defined herein. As defined in the document, hydrogen, C 1~6 Alkyl, C 2~6 Alkenyl, C 2~6 a Lukinir, C 3~7 Carbocyclyl, C 6~10 Aryl, 5-10 membered heteroaryl, and 5-10 membered heterocyclyl. Non-limiting examples include formyl, acetyl, Examples include propanoyl, benzoyl, and acrylic.
[0071] An "O-carboxy" group refers to a "-OC(=O)R" group, where R is as defined herein. As defined above, hydrogen, C 1~6 Alkyl, C 2~6 Alkenyl, C 2~6 Alkini Lu, C 3~7 Carbocyclyl, C 6~10 Aryl, 5-10 membered heteroaryl, and It is a 5- to 10-membered heterocyclyl.
[0072] A "C-carboxy" group refers to a "-C(=O)OR" group, where R is as defined herein. As defined above, hydrogen, C 1~6 Alkyl, C 2~6 Alkenyl, C 2~6 Alkini Lu, C 3~7 Carbocyclyl, C 6~10 aryl, 5- to 10-membered heteroaryl, and A non-limiting example is carboxyl (i.e. , -C(=O)OH).
[0073] An "acetal" group refers to RC(H)(OR')2, where R and R' are as defined herein. As defined in the document, hydrogen, C 1~6 Alkyl, C 2~6 Alkenyl, C 2~6 a Lukinir, C 3~7 Carbocyclyl, C 6~10 Aryl, 5-10 membered heteroaryl, and 5- to 10-membered heterocyclyl.
[0074] A "cyano" group refers to a "-CN" group.
[0075] A "sulfinyl" group refers to a "-S(=O)R" group, where R is as defined herein. As defined, hydrogen, C 1~6 Alkyl, C 2~6 Alkenyl, C 2~6 Alkynyl, C 3~7 Carbocyclyl, C 6~10 Aryl, 5-10 membered heteroaryl, and 5- 10-membered heterocyclyl.
[0076] A "sulfonyl" group refers to a "-SO2R" group, where R is defined herein. So, hydrogen, C 1~6 Alkyl, C 2~6 Alkenyl, C 2~6 Alkynyl, C 3~ 7Carbocyclyl, C 6~10 Aryl, 5-10 membered heteroaryl, and 5-10 membered heterocyclyl.
[0077] The "S-sulfonamide" group is "-SONR A R B " group, where R A and R B are each independently, as defined herein, hydrogen, C 1~6 Alkyl, C 2~6 Alkenyl, C 2~6 Alkynyl, C 3~7 Carbocyclyl, C 6~10 Ally and 5-10 membered heteroaryl, 5-10 membered heterocyclyl, and 5-10 membered heteroaryl.
[0078] An “N-sulfonamide” group is defined as “-N(R A )SO2R B " group, where R A Oh BiR B are each independently, as defined herein, hydrogen, C 1~6 Alki Lu, C 2~6 Alkenyl, C 2~6 Alkynyl, C 3~7 Carbocyclyl, C 6~10 a and is selected from aryl, 5- to 10-membered heteroaryl, and 5- to 10-membered heterocyclyl.
[0079] The "O-carbamyl" group is "-OC(=O)NR A R B " group, where R A and R B are each independently, as defined herein, hydrogen, C 1~6 Alkyl , C 2~6 Alkenyl, C 2~6 Alkynyl, C 3~7 Carbocyclyl, C 6~10 Ants and 5-10 membered heteroaryl, 5-10 membered heteroaryl, and 5-10 membered heterocyclyl.
[0080] The "N-carbamyl" group is "-N(R A )OC(=O)R B " group, where R A oh YobiRB are each independently, as defined herein, hydrogen, C 1~6 Al Kill, C. 2~6 Alkenyl, C 2~6 Alkynyl, C 3~7 Carbocyclyl, C 6~10 selected from aryl, 5- to 10-membered heteroaryl, and 5- to 10-membered heterocyclyl .
[0081] A "C-amide" group is defined as "-C(=O)NR A R B " group, where R A and R B teeth each independently, as defined herein, hydrogen, C 1~6 Alkyl, C2 ~6 Alkenyl, C 2~6 Alkynyl, C 3~7 Carbocyclyl, C 6~10 Aryl, It is selected from 5- to 10-membered heteroaryl, and 5- to 10-membered heterocyclyl.
[0082] An "N-amide" group is defined as "-N(R A )C(=O)R B " group, where R A and R B are each independently, as defined herein, hydrogen, C 1~6 Alkyl, C 2~6 Alkenyl, C 2~6 Alkynyl, C 3~7 Carbocyclyl, C 6~10 Ally and 5-10 membered heteroaryl, 5-10 membered heterocyclyl, and 5-10 membered heteroaryl.
[0083] The "amino" group is "-NR A R B " group, where R A and R Bare independent of each other As defined herein, hydrogen, C 1~6 Alkyl, C 2~6 Alkenyl , C 2~6 Alkynyl, C 3~7 Carbocyclyl, C 6~10 Aryl, 5-10 membered heptane Non-limiting examples include aryl, aryl, and 5- to 10-membered heterocyclyl. Examples include free amino (i.e., -NH2).
[0084] The term "hydrazine" or "hydrazinyl" as used herein refers to -NHNH Refers to the base.
[0085] The term "hydrazone" or "hydrazonyl" as used herein means [ka] Refers to the base.
[0086] The term "formyl" as used herein refers to a -C(O)H group.
[0087] The term "hydroxy" as used herein refers to an --OH group.
[0088] The term "azido" as used herein refers to the group --N3.
[0089] The term "thiol" as used herein refers to a -SH group.
[0090] The term "glycidyl ether" as used herein means [ka] Refers to...
[0091] The term "epoxy" as used herein means [ka] Refers to...
[0092] The term "ester" as used herein refers to an RC(=O)O-R' group, where: R and R' are independently alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl, alkenyl, cycloalkynyl, aryl, heteroaryl, heteroalicyclyl, raryl, (heteroalicyclyl)alkyl, or optionally substituted variants thereof; could be.
[0093] The term "carboxylic acid" or "carboxyl" as used herein means -C(O)O Point to H.
[0094] As used herein, the term "tetrazine" or "tetrazinyl" refers to a compound having four nitrogen atoms. The tetrazine may be optionally substituted.
[0095] As used herein, a substituent refers to a group in which one or more hydrogen atoms are exchanged with another atom or group. Unless otherwise indicated, a group is referred to as "substituted." Where possible, it is understood that the group is C1-C6 alkyl, C1-C6 alkenyl, C1- C6 alkynyl, C1-C6 heteroalkyl, C3-C7 carbocyclyl (halo, C1- C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, and C1-C6 halo C3-C7-carbocyclyl-C1-C6-alkoxy optionally substituted alkyl(halo, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, and C1-C6 haloalkoxy optionally substituted), 5-10 membered heterocyclyl ( Halo, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, and C 1-C6 haloalkoxy optionally substituted), 5-10 membered heterocyclyl-C1- C6-Alkyl (halo, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloa aryl (optionally substituted with halo, alkyl, and C1-C6 haloalkoxy); C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, and C1-C 6 haloalkoxy optionally substituted), aryl(C1-C6)alkyl(halo, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, and C1-C 6 haloalkoxy optionally substituted), 5-10 membered heteroaryl (halo, C1- C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, and C1-C6 halo 5-10 membered heteroaryl(C1-C6)alkyl, optionally substituted with alkoxy (halo, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, and and C1-C6 haloalkoxy), halo, cyano, hydroxy, C 1-C6 alkoxy, C1-C6 alkoxy(C1-C6)alkyl (i.e., ether ), aryloxy, sulfhydryl (mercapto), halo (C1-C6) alkyl (e.g. For example, -CF3), halo(C1-C6)alkoxy (for example, -OCF3), C1-C6 Alkylthio, arylthio, amino, amino(C1-C6) alkyl, nitro, O-ca Carbamyl, N-carbamyl, O-thiocarbamyl, N-thiocarbamyl, C-amide, N -Amide, S-sulfonamide, N-sulfonamide, C-carboxy, O-carboxy , acyl, cyanato, isocyanato, thiocyanato, isothiocyanato, sulfinyl, substituted with one or more substituents independently selected from sulfonyl, and oxo (=O); When a group is described as being "optionally substituted," it means that the group is "optionally substituted." When listed, the group can be substituted with the above substituents.
[0096] The naming convention for a radical is that it may be either a monoradical or a diradical, depending on the context. For example, it is understood that a substituent may require two points of attachment to the remainder of the molecule. When the substituent is a diradical, it is understood that the substituent is a diradical. For example, Substituents specified as alkyl include -CH2-, -CH2CH2-, and -CH Other radical naming conventions include diradicals such as 2CH(CH3)CH2-. Clarify that the alkene is a diradical such as "alkylene" or "alkenylene". .
[0097] The substituent is depicted as a diradical (i.e., has two points of attachment to the rest of the molecule). Whenever a substituent is present, the substituents can be attached in any direction unless otherwise indicated. It should be understood that, for example, -AE- or [ka] The substituents drawn as Substituents oriented to attach to the leftmost attachment point are included.
[0098] When the compounds disclosed herein have at least one stereocenter, they may be independently As enantiomers and diastereomers, or such isomers, including racemates Separation of the individual isomers or selective synthesis of the individual isomers can be achieved by This can be achieved by applying a variety of methods well known to those skilled in the art. All of these isomers and mixtures thereof are included within the scope of the compounds disclosed herein. Additionally, the compounds disclosed herein may be present in one or more crystalline or amorphous forms. Unless otherwise indicated, all of these forms include any polymorphic forms ( The compounds disclosed herein include those having the same or similar polymorphic forms. In addition, some of the compounds disclosed herein may form solvates with water (i.e., hydrates). or common organic solvents. Solvates are included within the scope of the compounds disclosed herein.
[0099] As used herein, a "nucleotide" refers to a heterocyclic base-containing nitrogen, sugar, and and one or more phosphate groups. These are the monomer units (precursors) of a nucleic acid sequence. In RNA, the sugar is ribose, in DNA Deoxyribose, i.e., lacking the hydroxyl group at the 2' position of ribose The nitrogen containing heterocyclic base may be a purine or pyrimidine base. The purine bases include adenine (A) and guanine (G), as well as their modified derivatives or Pyrimidine bases include cytosine (C), thymine (T), and uracil (C). C of deoxyribose, as well as modified derivatives or analogues thereof. The -1 atom bonds to the N-1 of a pyrimidine or the N-9 of a purine.
[0100] As used herein, a "nucleoside" is structurally similar to a nucleotide, but The term "nucleoside" is understood by those of skill in the art to mean a nucleotide that lacks any phosphate moiety at the 5' position. It is used herein in its ordinary and usual sense, as it should be understood. Examples include, but are not limited to: , ribonucleosides containing a ribose moiety, and deoxyribose containing a deoxyribose moiety. The modified pentose moiety is a nucleoside in which the oxygen atom is replaced by a carbon atom. and / or a pentose moiety in which a carbon is replaced by a sulfur atom or an oxygen atom A "nucleoside" is a monomer that may have a substituted base and / or sugar moiety. In addition, nucleosides form larger DNA and / or RNA polymers and oligomers. It can be incorporated into the
[0101] As used herein, the term "polynucleotide" generally refers to DNA (e.g., genomic DNA). DNA (e.g., cDNA), RNA (e.g., mRNA), synthetic oligonucleotides, and synthetic Polynucleotides refer to nucleic acids, including synthetic nucleic acid analogs. or combinations thereof, and natural or non-natural backbone linkages, e.g., phosphorothioate, ate, PNA, or 2'-O-methyl-RNA, or a combination thereof. obtain.
[0102] As used herein, the term "primer" refers to a single strand with a free 3'OH group. A primer is also defined as a nucleic acid that is modified at the 5' end and can be used in coupling reactions or or to allow the primer to bind to another moiety. The primer length can be any number of salts. As used herein, "BC" can be any base length and can include a variety of non-naturally occurring nucleotides. "BCN primer" or "BCN modified primer" refers to a primer that has a covalently linked bisphosphonate at the 5' end. Refers to a primer containing chloro[6.1.0]non-4-yne.
[0103] As used herein, the term "silane" refers to an organic compound that contains one or more silicon atoms. A non-limiting example of an organosilane compound is SiH4, or a compound with one hydrogen atom. Or halogenated SiH4 substituted with multiple halogen atoms. A non-limiting example is XR C -Si(OR D )3, where X is amino, vinyl, epoxy Non-hydrolyzable organic groups such as methacrylate, sulfur, alkyl, alkenyl, and alkynyl and R C is a spacer, e.g. -(CH2) n - (wherein n is 0 to 1000) Yes, R D is as defined herein, hydrogen, optionally substituted alkyl, optionally substituted substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted aryl, optionally substituted 5-10 membered heteroaryl, and optionally As used herein, the term "cycloalkyl" is selected from the group consisting of 5- to 10-membered heterocyclyl, ... and 10-membered heterocyclyl. A "run" may include a mixture of different silane compounds.
[0104] As used herein, the term "polymer" refers to a polymer that is made up of multiple repeating subunits or repeats. Non-limiting examples of polymer structures include linear polymers, branched polymers, and Non-limiting examples of linear polymers include block polymers. Non-limiting examples of branched polymers include copolymers and random copolymers. are star-shaped polymers, star-shaped polymers, which contain both hydrophilic and hydrophobic segments. or star-shaped block polymers, H-shaped polymers containing both hydrophilic and hydrophobic segments. Polymers, dumbbell polymers, comb polymers, brush polymers, dendronized polymers The polymers described herein also include polymers, ladders, and dendrimers. Other examples of polymeric configurations include, but are not limited to, However, cyclic block polymers, coil-cycle-coil oil) polymers.
[0105] As used herein, the prefix "photo" or "photo-" refers to The term refers to anything relating to electromagnetic radiation, light or electromagnetic radiation, including but not limited to: , the radio wave portion of the spectrum, the microwave portion, the infrared portion, the visible light portion, and the ultraviolet portion. Electromagnetic radiation, including one or more of the ranges commonly known as X-ray or gamma-ray portions The spectrum may include all or a portion of the spectrum, the portion of the spectrum being as described herein. Alternatively, the metal may be blocked by a metallic area on the surface, such as a metal such as In addition, parts of the spectrum are glass, plastic, silica, or other materials described herein. The material may pass through interstitial areas of a surface, such as areas made of other materials. In an embodiment, radiation capable of passing through metal may be used. or in addition, made of glass, plastic, silica, or other materials as described herein. It is possible to use radiation that is masked.
[0106] As used herein, the term "YES method" refers to a chemical method developed by Illumina. Yield Engineering Systems ("YE"), which has chemical vapor deposition processes This refers to chemical vapor deposition tools provided by the Company ("Chemical Vapor Deposition Systems"). It includes three different deposition systems. The automated YES-VertaCoat silane vapor system is available in 200 or 300 High volume with flexible wafer handling module capable of accommodating mm wafers Designed for production. Manually mounted YES-1224P Silane Deposition System is designed for versatile mass production with its configurable large volume chamber. Yes-LabKote is a low-cost, benchtop laboratory instrument ideal for feasibility studies and R&D. It is a type.
[0107] As used herein, the term "remaining surface fraction" refers to the fraction of the P5 / P7 surface primer that is stained. This refers to the intensity measured using TET QC, which is a primer for P5 and P7. - HiSeq(R), MiSeq(R), Genome Analyz Sequencing on the er® and NextSeq® platforms The surface of a commercially available flow cell sold by Illumina is used for the purpose of The sequences of the primers are described in US Patent Application Publication No. 2011 / 0059865. and P5 primer and P6 primer are described in The sequences of the 7 primers include: Paired-end set: P5: paired-end 5'→3' AATGATACGGCGACCACCGAGAUCTACAC P7: Paired-end 5'→3' CAAGCAGAAGACGGCATACGAG*AT Single Lead Set: P5: Single read: 5'→3' AATGATACGGCGACCACCGA P7: Single lead 5'→3' CAAGCAGAAGACGGCATACGA
[0108] In some embodiments, the P5 and P7 primers have a phosphoryl group at the 5′ end. Such a linker or spacer may be included to allow for cleavage. To provide other desired properties, such as to allow covalent attachment to a polymer or solid support, To confer affinity or to act as a spacer to position the cleavage site at an appropriate distance from the solid support. In some cases, 10 spacer nucleotides may be included to space the between the attachment points of the P5 or P7 primers to the polymer or solid support. In some embodiments, a polyT spacer is used, but However, other nucleotides and combinations thereof may also be used. In this case, the spacer is a 10T spacer. TET is complementary to the P5 / P7 primer. The dye-labeled oligonucleotides have the sequence TET, which is a P5 / P7 primer on the surface. The excess TET is washed away, leaving the bound dye-rich The degree is based on the Typhoon Scanner (General Electric) and other scanners. It can be measured by fluorescence detection using a Can instrument.
[0109] Polymers and DNA copolymers Polymers and Nucleic Acid Copolymers Having Repeating Units of Formula (I) and Formula (II) Some embodiments described herein include repeating units of formula (I) and formula (I I) repeating units for surface functionalization.
[0110] [ka]
[0111] In the formula, R 1a , R 2a , R 1b , and R 2b are each independently hydrogen, substituted alkyl, or optionally substituted phenyl; R 3a and R 3b each independently represents hydrogen, optionally substituted alkyl, optionally substituted phenyl, or any substituted C 7~14 aralkyl; L 1 and L 2 Each independently an optionally substituted alkylene linker, or an optionally substituted heteroaryl linker. The linker is selected from the group consisting of alkylene linkers.
[0112] In some embodiments, R 1a is hydrogen. In some embodiments, R 2a is hydrogen In some embodiments, R 3a In some embodiments, R is hydrogen. 1a Water or optionally substituted alkyl, preferably C 1~6 alkyl; R 2a oh YobiR 3a are each hydrogen. 1a , R 2a and R 3a are each hydrogen. 1bis hydrogen. So, R 2b is hydrogen. In some embodiments, R 3b is hydrogen. In terms of form, R 1b is hydrogen or optionally substituted alkyl, preferably C 1~6 Alkyl Selected from R 2b and R 3b are each hydrogen. 1 b , R 2b and R 3b Each of L is hydrogen. 1 is optionally In some such embodiments, L is a substituted alkylene. 1 is optionally replaced In some other embodiments, L is methylene. 1 is optionally substituted ethylene In some further embodiments, L 1 is optionally substituted propylene. In this embodiment, L 1 is an optionally substituted heteroalkylene linker. In such an embodiment, L 1 is (CH2)m optionally substituted with one or more oxo groups -NH-(CH2)n-, wherein m and n are each independently 1 to 10. In some embodiments, L is an integer selected from the 2 is an optionally substituted alkylene. In some such embodiments, L 2 is an optionally substituted methylene. In another embodiment, L 2 is optionally substituted ethylene. Well then, L 2 is optionally substituted propylene. In some embodiments, the reaction of formula (I) The repeating unit may also be represented by formula (Ia) or formula (Ib), and formula (II) may be represented by formula (IIa): It can also be expressed by:
[0113] [ka]
[0114] In the formula, R 1a and R 1b are each selected from hydrogen or methyl. In one embodiment, the polymer comprises repeating units of formula (Ia) and formula (IIa). In an embodiment, the polymer comprises repeat units of formula (Ib) and formula (IIa). Or in some embodiments of the repeat unit of formula (IIa), the amino functionality may be reacted with an inorganic salt, e.g. In some embodiments, the molar ratio of the repeating units of formula (I) and formula (II) is In some such embodiments, the ratio is about 1:1. In some such embodiments, the molar ratio of repeating units of formula (Ib) is about 1:1. ) and the repeating unit of formula (IIa) is about 1:1.
[0115] In some embodiments, the polymer may further include polyacrylamides, polyacrylates, poly Polyurethane, polysiloxane, silicone, polyacrolein, polyphosphazene, poly A repeating unit selected from the group consisting of isocyanates, polyols, and polysaccharides. Some such embodiments may include one or more of the following: In the polymer, the polymer further comprises a polymer of formula (IIIa) or (IIIb) or both. It may contain one or more repeating units of acrylamide.
[0116] [ka]
[0117] In the formula, R 4a , R 4b , and R 5b are hydrogen or C 1~3 Select from alkyl Selected, R 5a , R 6a , R 6b , and R 7b are each independently hydrogen, Replaced C 1~6 In some embodiments, the aryl group is selected from the group consisting of alkyl, aryl ... In the embodiment, R 4a , R 4b , and R 5b are each selected from hydrogen or methyl; In some embodiments, R 6b and R 7b are hydrogen. is R 5a or R 6a At least one of is hydrogen. In some such embodiments, is R 5a and R 6a and R are hydrogen. 5a or R 6a At least one of R 5a Oh BiR 6a In some such embodiments, both of the reactants of formula (IIIa) are methyl. The repeating units are (IIIa1), (IIIa2), or (IIIa3): [ka] In some such embodiments, the repeat unit of formula (IIIb) is represented by: IIIb1): [ka] It can also be expressed by:
[0118] In some particular embodiments, the polymer is represented by Formula (Ib), Formula (IIa), and Formula (IIb). In some further embodiments, the polymer comprises a repeat unit of formula (Ib), formula (Ic). Some such repeating units include those of formula (IIa), formula (IIIa), and formula (IIIb). In an embodiment, the molar percentage of formula (IIIa) is about 85% to about 90%. In such an embodiment, the molar percentage of Formula (Ib) and Formula (IIa) is about 5% each. In one embodiment, the polymer comprises a compound having the formula (I) in a molar percentage of about 90% to about 5% to about 5%. In another embodiment, the repeating units include those of formula (IIa1), formula (Ib), and formula (IIa). The polymers are represented by the formula (IIIa1), the formula (Ib), and the like, in a molar percentage of about 85% to about 5% to about 10%. In yet another embodiment, the polymer comprises a repeat unit of formula (IIa): % to about 5% to about 5% molar percentage of the formula (IIIa2), the formula (Ib), and the formula (IIa In some further embodiments, the polymer further comprises about 0.5 mol % up to about 2 mol % of repeat units of formula (IIIb1).
[0119] Some embodiments described herein include a repeating unit of formula (I) as described herein. A functionalized oligonucleotide covalently attached to a polymer having a repeating unit of formula (II) In some embodiments, the polymer further comprises the above-mentioned Various different polymer backbone repeat units of formula (IIIa) or formula (IIIb ), or both. In embodiments, the covalent bond between the functionalized oligonucleotide and the polymer is a structural moiety. [ka] or combinations thereof, wherein * represents a point of attachment to a functionalized oligonucleotide. In some such embodiments, the covalent bond between the functionalized oligonucleotide and the polymer is Bonded bonds are structural parts [ka] In some other such embodiments, the functionalized oligonucleotide and the polymer The covalent bond between the structural parts [ka] In some such embodiments, the polymer comprises a Covalent bonds are structural parts [ka] In some embodiments, one or more functional groups of the functionalized oligonucleotide are The grafted polymer is prepared by reacting one or more of the The functional moieties include alkynes, cycloalkenes, cycloalkynes, heterocycloalkenes, and heterocycloalkenes. A heterocycloalkyne, an optionally substituted variant thereof, or a combination thereof or the one or more functional moieties are selected from the group consisting of alkynes, cycloalkenes, cycloalkene, Heterocycloalkynes, heterocycloalkenes, heterocycloalkynes, optionally substituted thereof In some such embodiments, the present invention is selected from the group consisting of: The one or more functional groups include an alkyne, or the one or more functional groups In some other embodiments, the functional group is selected from an alkyne. The moieties include norbornene, cyclooctyne, bicyclononyne, and optionally substituted variants thereof. or a combination thereof, norbornene, cyclooctyne, bicyclononyne, and optionally substituted variants thereof or a combination thereof. In some such embodiments, the polymer is chloro[6.1.0]nona-4-yne. The azide group may be attached to one or more functional groups of the functionalized oligonucleotide, such as a bicyclo[ 6.1.0] The grafted polymer is prepared by reacting with non-4-yne.
[0120] Polymers and nucleic acid copolymers having repeating units of formula (IV) Some embodiments described herein include a repeat unit of formula (IV) as shown above. Concerning polymers for face functionalization.
[0121] [ka]
[0122] In the formula, R 1c and R 2c each independently represents hydrogen, optionally substituted alkyl, or optionally substituted phenyl; R 3c is hydrogen, optionally substituted alkoxy phenyl, optionally substituted phenyl, or optionally substituted C 7~14 Select from aralkyl Ar is optionally substituted C 6~10 Aryl, or an optionally substituted 5-membered or 6-membered heteroaryl; R A is an optionally substituted tetrazine, L 3 may be a single bond, an optionally substituted alkylene linker, or an optionally substituted heterocyclic The linker is selected from the group consisting of alkylene linkers.
[0123] In some embodiments, R 1c is hydrogen. In some embodiments, R 2c is hydrogen In some embodiments, R 3c is hydrogen. In some embodiments, R 1c Water or optionally substituted alkyl, preferably C 1~6 alkyl; R 2c oh YobiR 3c Each is hydrogen. In some embodiments, R 1c , R 2c , and R 3c In some embodiments, Ar is optionally substituted phenyl. In some embodiments, L 3 is a single bond. In some embodiments, The repeating unit is also represented by formula (IVa).
[0124] [ka]
[0125] In the formula, R 1c is selected from hydrogen or methyl.
[0126] In some embodiments, the polymer may further include polyacrylamides, polyacrylates, poly Polyurethane, polysiloxane, silicone, polyacrolein, polyphosphazene, poly A repeating unit selected from the group consisting of isocyanates, polyols, and polysaccharides. Some such embodiments may include one or more of the following: In the above, the polymer may further be represented by the formula (IIIa) or the formula (IIIb ) polyacrylamide repeating units.
[0127] Some embodiments described herein include a repeating unit of formula (IV) as described herein. A grafted polymer comprising a functionalized oligonucleotide covalently attached to a polymer having a In some embodiments, the polymer may further comprise a variety of different polymer backbones as described above. Repeating units of the formula (IIIa) or (IIIb) or both, In some embodiments, the functionalized oligonucleotide may include one or more repeating units of a aryl amide. The covalent bond between the nucleotide and the polymer is [ka] or combinations thereof, wherein * represents a functionalized oligonucleotide of the polymer In some such embodiments, the functionalized oligonucleotide and the polymer The covalent bond between the structural moiety [ka] In some other such embodiments, the functionalized oligonucleotide and the polymer The covalent bond between the structural parts [ka] In some embodiments, one or more functional groups of the functionalized oligonucleotide are The grafted polymer is prepared by reacting one or more of the The functional moieties include alkynes, cycloalkenes, cycloalkynes, heterocycloalkenes, and heterocycloalkenes. A heterocycloalkyne, an optionally substituted variant thereof, or a combination thereof or the one or more functional moieties are selected from the group consisting of alkynes, cycloalkenes, cycloalkene, Heterocycloalkynes, heterocycloalkenes, heterocycloalkynes, optionally substituted thereof In some such embodiments, the present invention is selected from the group consisting of: The functional moiety or moieties may include norbornene, cyclooctyne, bicyclononyne, or any or a combination thereof, or or the multiple functional moieties are norbornene, cyclooctyne, bicyclononyne, optionally substituted In one embodiment, the polypeptide may be selected from the polypeptides listed above, their variants, or combinations thereof. Bicyclononyne is bicyclo[6.1.0]non-4-yne. In embodiments, the tetrazine groups of the polymer are attached to one or more of the functionalized oligonucleotides. By reacting with a functional group such as bicyclo[6.1.0]nona-4-yne, A fluorinated polymer is prepared.
[0128] Polymers and nucleic acid copolymers having repeating units of formula (V) Some embodiments described herein include surface functional groups comprising repeating units of formula (V) as described above. Polymers for Functionalization.
[0129] [ka]
[0130] In the formula, R 1d and R 2d each independently represents hydrogen, optionally substituted alkyl, or optionally substituted phenyl; R 3d are hydrogen, optionally substituted optionally substituted alkyl, optionally substituted phenyl, or optionally substituted C 7~14 Aral Selected from Kill, R B is an azide, an optionally substituted amino, a Boc-protected amino, a hydride, alkoxy, thiol, alkynyl, alkenyl, halo, epoxy, tetrazinyl, or a L 4 and L 5 each independently represents an optionally substituted alkyl group; The linker is selected from an optionally substituted heteroalkylene linker or an optionally substituted heteroalkylene linker.
[0131] In some embodiments, R 1d is an alkyl group, preferably C 1~6 It is an alkyl group. In such an embodiment of the invention, R 1d is methyl. In some other embodiments, R 1d is hydrogen. In some embodiments, R 2d is hydrogen. In some embodiments, R 3d is hydrogen. In some embodiments, R 2d and R 3d are hydrogen. In some embodiments, R B is an azide, amino, or Boc protected amino, or In some embodiments, L is selected from the group consisting of 4 is an optionally substituted aryl In some such embodiments, L 4 is a methylene linker In some embodiments, L 5 is an optionally substituted heteroalkylene linker. In some such embodiments, L 5 teeth, [ka] wherein n is an integer from 1 to 50. In some embodiments, the repeat unit of formula V is , also represented by formula (Va) or formula (Vb).
[0132] [ka]
[0133] In the formula, R 1d are each independently selected from hydrogen or methyl. In such embodiments, n is an integer from 1 to 20. In some such embodiments, n is , an integer from 1 to 10. In some such embodiments, n is an integer from 1 to 5. In one embodiment, n is 3. In some embodiments, the polymer has formula (Va) and Formula (Vb)
[0134] In some embodiments, the polymer further comprises a compound represented by Formula (VIa) or Formula (VIb), or The repeat units may include both of the above.
[0135] [ka]
[0136] In the formula, R 1e , R 2e , R 1f , and R 2f are each independently hydrogen, substituted alkyl, or optionally substituted phenyl. In embodiments, R 1e is alkyl, preferably C 1~6 Alkyl, for example methyl. In some other embodiments, R 1eis hydrogen. In some embodiments, R 2e is hydrogen In some such embodiments, R 1f is alkyl, preferably C 1~6 Alki In some other embodiments, R 1f is hydrogen. In terms of form, R 2f is hydrogen.
[0137] In some embodiments, the polymer may further include polyacrylamides, polyacrylates, poly Polyurethane, polysiloxane, silicone, polyacrolein, polyphosphazene, poly A repeating unit selected from the group consisting of isocyanates, polyols, and polysaccharides. Some such embodiments may include one or more of the following: In the above, the polymer may further be represented by the formula (IIIa) or the formula (IIIb ) polyacrylamide repeating units.
[0138] Some embodiments described herein include a repeating unit of formula (V) as described herein. A grafted polymer comprising a functionalized oligonucleotide covalently attached to a polymer having a In some embodiments, the polymer further comprises a compound represented by formula (VIa) or formula (VIb In some embodiments, the functionalized oligonucleotide may include repeat units of either 1 or 2. The covalent bond between the amide and the polymer is [ka] or combinations thereof, wherein * represents a functionalized oligonucleotide of the polymer In some such embodiments, the functionalized oligonucleotide and the polymer The covalent bond between [ka] In some embodiments, one or more functional groups of the functionalized oligonucleotide are The grafted polymer is prepared by reacting one or more of the Functional groups include optionally substituted amino, hydroxy, thiol, carboxyl, acid anhydride, or a combination thereof, or the one or more functional groups are any Arbitrarily substituted amino, hydroxy, thiol, carboxyl, acid anhydride, or the like In some embodiments, the functionalized oligonucleotide is selected from the group consisting of: In some such embodiments, the amino In some such embodiments, the glycidyl ether group of the polymer is unsubstituted. and reacting the aryl or epoxy group with one or more amino groups of the functionalized oligonucleotide. In some such embodiments, the grafted polymer is prepared by reacting The epoxy groups of the polymer are derived from repeat units of formula (VIa).
[0139] Base material Some embodiments described herein include a repeating unit of formula (I) as described herein. a substrate having a first surface having a polymer covalently bonded thereto, the polymer having a repeating unit of formula (II) In some embodiments, the polymer further comprises polyacrylamide, polyacrylate, Polyurethane, polysiloxane, silicone, polyacrolein, polyphosphazene , polyisocyanates, polyols, and polysaccharides. Some such embodiments may include one or more repeating units or combinations thereof. In embodiments, the polymer further comprises a compound represented by formula (IIIa) or formula (IIIb) having the structure shown below: In some embodiments, the polyacrylamide repeat unit may include one or more repeat units of IIb). In the present invention, the covalent bond between the polymer and the substrate is formed by an amine-epoxy ring-opening reaction. In some embodiments, the covalent bond between the polymer and the first surface of the substrate is [ka] or combinations thereof, wherein the substituted amino is present in the repeat unit of formula (II) where * indicates the point of attachment of the polymer to the first surface of the substrate. In embodiments, the covalent bond between the polymer and the first surface is [ka] In some embodiments, the polymer comprises a first plurality of functional groups covalently attached to the first surface. The first plurality of functional groups include vinyl, acrylic, Aryl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, cyclo Alkynyl, heterocycloalkynyl, nitrene, aldehyde, hydrazinyl, glycidyl ethers, epoxies, carbenes, isocyanates, maleimides, optionally substituted or a combination thereof, or is vinyl, acryloyl, alkenyl, cycloalkenyl, heterocycloalkenyl, Alkynyl, cycloalkynyl, heterocycloalkynyl, nitrene, aldehyde, hydride Rhasinyl, glycidyl ether, epoxy, carbene, isocyanate, maleimide, The amino acid sequence may be selected from any of the following combinations: In such embodiments, the first plurality of functional groups includes an epoxy group, or the first The plurality of functional groups is selected from epoxy groups. In one embodiment, the epoxy groups have the structure [ka] In some embodiments, an amino group of the polymer is reacted with an epoxy group of the first surface. In some embodiments, a substrate is prepared by adding the first plurality of functional groups described above. and pretreating the surface with a functionalized silane containing a first functional group of the functionalized silane via reaction with the first functional group of the functionalized silane. A polymer is covalently attached to the first surface.
[0140] In some embodiments, the substrate further comprises a functionalized oligonucleotide covalently attached to the polymer. In some embodiments, the covalent bond between the oligonucleotide and the polymer comprises an In some embodiments, the functionalized oligonucleoside is formed by a dihydro-click cycloaddition reaction. The covalent bond between the tide and the polymer is [ka] or combinations thereof, where * represents a polymeric, functionalized oligonucleotide. In some such embodiments, one or more of the functionalized oligonucleotides A functionalized oligonucleotide is prepared by reacting one or more functional groups with the azide group of the polymer. The functional moiety or moieties may include an alkyne, a silyl group, a cyclic ... cycloalkenes, cycloalkynes, heterocycloalkenes, heterocycloalkynes, optionally or any combination thereof, or Or the functional moieties are alkynes, cycloalkenes, cycloalkynes, heterocyclos Alkenes, heterocycloalkynes, optionally substituted variants thereof, or In some such embodiments, one or more of the functional groups are selected from a combination. In some other embodiments, the one or more functional moieties include an alkyne. These include norbornene, cyclooctyne, bicyclononyne, and their optionally substituted variants. or a combination thereof, norbornene, cyclooctyne, bicyclononyne, and optionally substituted variants thereof or a combination thereof. In some embodiments, the azide group of the polymer is chloro[6.1.0]nona-4-yne. By reacting with one or more alkyne moieties of a functionalized oligonucleotide, In some other embodiments, the functionalized oligonucleotide is covalently attached to the polymer. The azide group of the functionalized oligonucleotide is attached to one or more bicyclo[6.1.0]no groups. Covalent attachment of functionalized oligonucleotides to polymers by reaction with nine-4-yne To make.
[0141] Some embodiments described herein include repeating groups of formula (IV) as described herein. In some embodiments, the present invention relates to a substrate comprising a first surface having a polymer having covalently attached thereto a unit. The polymers are further classified as polyacrylamides, polyacrylates, polyurethanes, polysilanes, etc. Roxane, silicone, polyacrolein, polyphosphazene, polyisocyanate, poly repeating units selected from the group consisting of saccharides, oligosaccharides, and polysaccharides, or their In some such embodiments, the polymer may further comprise one or more of a combination. Further, a polyacrylamide having the following structure represented by formula (IIIa) or (IIIb) is provided. In some embodiments, the polymer may include one or more repeat units of amide. The covalent bond is formed by the tetrazine Diels-Alder reaction, which is carried out by the addition of nitrogen gas. In some embodiments, the covalent bond between the polymer and the first surface of the substrate is structural part [ka] or combinations thereof, where * indicates the point of attachment of the polymer to the first surface. In some such embodiments, the covalent bond between the polymer and the first surface is [ka] In some other such embodiments, the covalent bond between the polymer and the first surface comprises: structural part [ka] In some embodiments, the polymer comprises a first plurality of functional groups covalently attached to the first surface. The first plurality of functional groups include vinyl, acrylic, Aryl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, cyclo Alkynyl, heterocycloalkynyl, nitrene, aldehyde, hydrazinyl, glycidyl ethers, epoxies, carbenes, isocyanates, maleimides, optionally substituted or a combination thereof, or is vinyl, acryloyl, alkenyl, cycloalkenyl, heterocycloalkenyl, Alkynyl, cycloalkynyl, heterocycloalkynyl, nitrene, aldehyde, hydride Rhasinyl, glycidyl ether, epoxy, carbene, isocyanate, maleimide, The amino acid sequence may be selected from any of the following combinations: In such embodiments, the first plurality of functional groups includes optionally substituted cycloalkenyl groups. or the first plurality of functional groups comprises an optionally substituted cycloalkenyl group. In one embodiment, the cycloalkenyl is norbornene. In some embodiments, the tetrazine groups of the polymer are reacted with the norbornene groups of the first surface. In some embodiments, the substrate is prepared by: and reacting the surface with a functionalized silane comprising a first plurality of functional groups of the functionalized silane to form a first plurality of functional groups. The polymer is covalently attached to the first surface.
[0142] In some embodiments, the substrate further comprises a functionalized oligonucleotide covalently attached to the polymer. In some embodiments, the covalent bond between the oligonucleotide and the polymer comprises a tetrade. It is formed by the Razin-Diels-Alder reaction, which results in the elimination of nitrogen gas. In some embodiments, the covalent bond between the functionalized oligonucleotide and the polymer comprises a structural moiety minutes [ka] or combinations thereof, where * represents a polymeric, functionalized oligonucleotide. In some such embodiments, the functionalized oligonucleotide and the polymer The covalent bond between the structural moiety [ka] In some such embodiments, one or more of the functionalized oligonucleotides Functionalized oligonucleotides are prepared by reacting the functional groups with the tetrazine groups of the polymer. The one or more functional moieties are covalently attached to a polymer, the functional moiety or moieties being selected from the group consisting of alkyne, cycloalkyl ... Alkenes, cycloalkynes, heterocycloalkenes, heterocycloalkynes, optionally substituted or any combination thereof, or The multiple functional moiety is an alkyne, a cycloalkene, a cycloalkyne, a heterocycloalkene, Heterocycloalkynes, heterocycloalkynes, optionally substituted variants thereof, or combinations thereof In some such embodiments, the one or more functional moieties are selected from the group consisting of The moieties include norbornene, cyclooctyne, bicyclononyne, and optionally substituted variants thereof. or a combination thereof, The compounds are norbornene, cyclooctyne, bicyclononyne, and their optionally substituted variants. In one embodiment, the bicyclononyne is selected from the group consisting of bicyclononyne, In some such embodiments, the polymer is cyclo[6.1.0]nona-4-yne. Functionalize oligonucleotides with one or more bicyclo[6.1.0] tetrazine groups Functionalized oligonucleotides can be coupled to polymers by reacting with the nona-4-yne moiety. To bond.
[0143] Some embodiments described herein include a repeating unit of formula (V) as described herein. In some embodiments, the present invention relates to a substrate comprising a first surface having a polymer having a covalently attached thereto, the polymer having a moiety. The polymer may further include polyacrylamides, polyacrylates, polyurethanes, polysiloxanes, etc. Xanthane, silicone, polyacrolein, polyphosphazene, polyisocyanate, poly A repeating unit or a combination thereof selected from the group consisting of saccharides, saccharides, and polysaccharides. In some embodiments, the polymer may further comprise one or more of the formula (V In some embodiments, the repeat unit may comprise either formula (Ia) or formula (VIb), or both. The covalent bond between the polymer and the substrate is formed by an amine-epoxy ring-opening reaction. In another embodiment, the covalent bond between the polymer and the substrate is formed by an azide click cycloaddition reaction. In some embodiments, the covalent bond between the polymer and the first surface of the substrate is , structural part [ka] or combinations thereof, where * indicates the point of attachment of the polymer to the first surface. In some such embodiments, the covalent bond between the polymer and the first surface is [ka] In some other embodiments, the covalent bond between the polymer and the first surface comprises a structural moiety [ka] or combinations thereof, where * indicates the point of attachment of the polymer to the first surface. In some such embodiments, the covalent bond between the polymer and the first surface is [ka] In some other such embodiments, the covalent bond between the polymer and the first surface comprises: structural part [ka] In some embodiments, the polymer comprises a first plurality of functional groups covalently attached to the first surface. The first plurality of functional groups include vinyl, acrylic, Aryl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, cyclo Alkynyl, heterocycloalkynyl, nitrene, aldehyde, hydrazinyl, glycidyl ethers, epoxies, carbenes, isocyanates, maleimides, optionally substituted or a combination thereof, or is vinyl, acryloyl, alkenyl, cycloalkenyl, heterocycloalkenyl, Alkynyl, cycloalkynyl, heterocycloalkynyl, nitrene, aldehyde, hydride Rhasinyl, glycidyl ether, epoxy, carbene, isocyanate, maleimide, The amino acid sequence may be selected from any of the following combinations: In such embodiments, the first plurality of functional groups includes optionally substituted cycloalkenyl groups. or the first plurality of functional groups comprises an optionally substituted cycloalkenyl group In one embodiment, the cycloalkenyl is norbornene. In one embodiment, the azide groups of the polymer are reacted with the norbornene groups of the first surface to form the groups. In some other embodiments, the first plurality of functional groups includes glycidyl ethers. or the first plurality of functional groups includes a glycidyl ether or epoxy group. In some embodiments, the Boc-protected amine of the polymer is selected from the group consisting of an aryl group and an epoxy group. The amino groups of the polymer are then deprotected and then bonded to the glycidyl ether or epoxy groups of the first surface. In some embodiments, the substrate is prepared by reacting the first Pretreating the surface with a functionalized silane containing multiple functional groups, and applying a first functional group of the functionalized silane to the surface. The polymer is covalently attached to the first surface via reaction with
[0144] In some embodiments, the substrate further comprises a functionalized oligonucleotide covalently attached to the polymer. In some embodiments, the covalent bond between the oligonucleotide and the polymer comprises an In some embodiments, the functionalized oligonucleotide is formed by a cyclic epoxy ring-opening reaction. The covalent bond between the amide and the polymer is [ka] or combinations thereof, where * represents a polymeric, functionalized oligonucleotide. In some embodiments, the linkage between the functionalized oligonucleotide and the polymer is shown. Covalent bonds are structural parts [ka] In some such embodiments, one or more of the functionalized oligonucleotides Functionalized oligonucleotides are attached to the polymer by reacting the functional groups with the epoxy groups of the polymer. The functional group or groups may be optionally substituted amines. Contains no, hydroxy, thiol, carboxyl, anhydride, or a combination thereof. or the one or more functional groups are optionally substituted amino, hydroxyl, The group is selected from thiol, thiol, carboxyl, acid anhydride, or a combination thereof. In some such embodiments, the one or more functional groups include an optionally substituted aryl group. or wherein said one or more functional groups are optionally substituted amino groups. In some such embodiments, the epoxy groups of the polymer are selected from the functionalized oligonucleotides. The functionalized oligonucleotides are then reacted with the amino groups of the nucleotides to form polymers. Covalently bond to.
[0145] In the embodiments described herein, the substrate material may be glass, silica, plastic, stone, or other suitable material. In some embodiments, the material may include a silicon, a metal, a metal oxide, or a combination thereof. The substrate comprises glass. In some embodiments, the first surface of the substrate comprises a polymeric coating region. This includes both active and inactive regions.
[0146] Preparation of the substrate surface Some embodiments described herein include a first surface having a first plurality of covalently attached functional groups. a substrate comprising a polymer having functionalized oligonucleotides covalently attached thereto; a substituted or unsubstituted polymer, wherein the polymer comprises a second plurality of functional groups; reacting a first plurality of functional groups on the first surface with a second plurality of functional groups on the polymer; As a result, the polymer is covalently attached to the first surface of the substrate to form a grafted polymer. The present invention relates to a process or method for immobilizing a mer to a first surface of a substrate.
[0147] In some embodiments of the methods described herein, a first surface of a substrate is pretreated with a functionalized silane. In some embodiments, the functionalized silane comprises a first plurality of functional groups. Silane is deposited on the surface by chemical vapor deposition (CVD). In some such embodiments, The functionalized silanes were obtained from Yield Engineering Systems (YES) It can be applied to the first surface by a CVD method using an oven.
[0148] In some embodiments of the methods described herein, the third plurality of functional groups of the polymer are The grafted polymer is formed by reacting the grafted polymer with one or more functional groups of the grafted oligonucleotide. In some other embodiments, the one or more of the functionalized oligonucleotides form a polymer. reacting the plurality of functional groups with a monomer containing a third plurality of functional groups; Polymerization to form a polymer, thereby copolymerizing the functionalized oligonucleotide into the polymer. By combining them, a grafted polymer is formed.
[0149] In some embodiments of the methods described herein, the second plurality of functional groups of the polymer are For example, the second and third functional groups of the polymer are the same. The polyfunctional groups and the third functional group can both be tetrazines. The functional groups in the second plurality of functional groups of the mer are different from the functional groups in the third plurality of functional groups of the polymer. different.
[0150] The polymer backbones used in the methods described herein may be linear, branched, hyperbranched, or dendritic. The final polymer structure can be, for example, a random copolymer, a block copolymer, The polymers may be of various configurations, including comb, star, or other polymeric structures. Polyacrylamides, polyacrylates, polyurethanes, polysiloxanes, etc. San, silicone, polyacrolein, polyphosphazene, polyisocyanate, polyo Different types of polymer backbones, including saccharides, polysaccharides, etc., can be synthesized using the methods described herein. In some embodiments, the polymer can be a polyacrylamide backbone. In some other embodiments, the polymer comprises a polyacrylate backbone. In other embodiments, the polymer comprises a polyurethane backbone. In some further embodiments, the polymer comprises a polyphosphazene backbone. comprises a dendrimer backbone.
[0151] In some embodiments of the methods described herein, the first plurality of functional groups on the first surface comprises: Vinyl, acryloyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl Alkynyl, cycloalkynyl, heterocycloalkynyl, nitrene, aldehyde, hydrazine Nyl, glycidyl ether, epoxy, carbene, isocyanate, maleimide, optionally or a combination thereof, or The first plurality of functional groups may be vinyl, acryloyl, alkenyl, cycloalkenyl, heptyl, cycloalkenyl, alkynyl, cycloalkynyl, heterocycloalkynyl, nitrile Aldehydes, hydrazinyl, glycidyl ethers, epoxy, carbene, isocyanates amides, maleimides, optionally substituted variants thereof, or combinations thereof. In some such embodiments, the first plurality of functional groups includes a cycloalkenyl group. glycidyl ether, epoxy, optionally substituted variants thereof, or or the first plurality of functional groups includes a combination of cycloalkenyl, glycidyl, ether, epoxy, optionally substituted variants thereof, or combinations thereof. In some further embodiments, the first plurality of functional groups is selected from norbornene. In some other embodiments, the first plurality of functional groups is selected from norbornene. In some embodiments, the first plurality of functional groups includes epoxy. The first plurality of functional groups includes glycidyl ethers.
[0152] In some embodiments of the methods described herein, the functional groups of the polymer include amino, tetrahydrofuran ... Razinyl, azido, carboxyl, hydroxyl, thiol, aldehyde, halo, alkenyl may include alkyl, alkynyl, epoxy, glycidyl ether, etc., or may be a polymer Functional groups include amino, tetrazinyl, azido, carboxyl, hydroxyl, thiol, and alkoxy groups. Dehyde, halo, alkenyl, alkynyl, epoxy, glycidyl ether, etc. In some embodiments of the methods described herein, the second plurality of functional groups of the polymer are are amino, tetrazinyl, azido, carboxyl, hydroxyl, thiol, and aldehyde. , optionally substituted variants thereof, or combinations thereof; or The second plurality of functional groups of the polymer may be amino, tetracyclyl, azido, carboxyl, hydroxyl, an alkoxy, a thiol, an aldehyde, an optionally substituted variant thereof, or a combination thereof; In some such embodiments, the second plurality of functional groups includes an aryl group, an aryl group, or a combination thereof. or a protected amino, e.g., a Boc-protected amino, or a second multiple functional group. The functional group is selected from amino or protected amino, such as Boc-protected amino. In one embodiment, the second plurality of functional groups includes an optionally substituted tetrazinyl. In yet another embodiment of the moiety, the second plurality of functional groups includes azide.
[0153] In some embodiments of the methods described herein, the third plurality of functional groups of the polymer include: Azido, tetrazinyl, glycidyl, epoxy, alkynyl, optionally substituted thereof or a third plurality of functional groups on the polymer. The groups include azido, tetrazinyl, glycidyl, epoxy, alkynyl, optionally substituted and Some such embodiments are selected from these variants, or combinations thereof. In some other embodiments, the third plurality of functional groups includes azide. The functional group includes an optionally substituted tetrazinyl. In some further embodiments, and the third plurality of functional groups includes alkynyl. In some still further embodiments, the third The functional groups include optionally substituted glycidyl ethers.
[0154] In some embodiments of the methods described herein, the one of the functionalized oligonucleotides Or multiple functional moieties include amino, azido, carboxyl, acid anhydride, tetrazine, Epoxy, glycidyl ether, vinyl, acryloyl, alkenyl, cycloalkenyl , alkynyl, cycloalkynyl, nitrene, aldehyde, hydrazinyl, maleimide, Any optionally substituted variants thereof, or combinations thereof, or The one or more functional moieties of the functionalized oligonucleotide may be amino, azido, carbo Xyl, acid anhydride, tetrazine, epoxy, glycidyl ether, vinyl, acryloyl , alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, nitrene, aldehyde hydrazinyl, maleimide, optionally substituted variants thereof, or combinations thereof In some further embodiments, the functionalized oligonucleotide is selected from the group consisting of The functional moiety or moieties may be alkynyl, cycloalkenyl, cycloalkynyl, , amino, azido, hydroxy, thiol, carboxyl, acid anhydride, optionally substituted or a combination thereof, or a functionalized oligonucleotide. The one or more functional moieties of the oxidase may be alkynyl, cycloalkenyl, cycloalkenyl, Alkynyl, amino, azido, hydroxy, thiol, carboxyl, acid anhydride, Some such variants may be selected from the group consisting of those modified variants, or combinations thereof. In certain embodiments, the one or more functional moieties include cycloalkynyl, e.g., bicycloalkynyl. In some other embodiments, the compound is selected from the group consisting of bromo[6.1.0]non-4-yne (BCN). In some further embodiments, the one or more functional moieties include alkynyl. In some still further embodiments, the one or more functional moieties include an azide. The one or more functional moieties include an optionally substituted amino.
[0155] In some embodiments of the methods described herein, the grafted polymer is a polymer having a structure as described herein. As described above, a polymer having a repeating unit of formula (I) and a repeating unit of formula (II) is covalently bonded to the polymer. In some such embodiments, the first surface comprises a functionalized oligonucleotide attached thereto. The first plurality of functional groups includes epoxy groups. In one embodiment, the epoxy groups are [ka] In some such embodiments, the amino groups of the polymer are bonded to the epoxy groups of the first surface. The reaction causes the grafted polymer to become covalently attached to the first surface.
[0156] In some embodiments of the methods described herein, the grafted polymer is a polymer having a structure as described herein. As described above, a functionalized oligonucleotide is covalently attached to a polymer having a repeat unit of formula (IV). In some such embodiments, the first plurality of functional groups on the first surface comprises: Optionally substituted cycloalkenyl groups, including, for example, optionally substituted norbornene. In some such embodiments, the tetrazine groups of the polymer are bonded to the norbornene groups of the first surface. The grafted polymer is covalently attached to the first surface by reacting with
[0157] In some embodiments of the methods described herein, the grafted polymer is a polymer having a molecular weight of 100 or more, preferably 100 or more, more ... In order to achieve this, a functionalized oligonucleotide is covalently attached to a polymer having a repeat unit of formula (V) In some embodiments, the polymer further comprises a thiol group having the formula (I), as described herein. Some such repeat units may include repeat units of formula (VIa) or formula (VIb) or both. In embodiments, the first plurality of functional groups includes optionally substituted cycloalkenyl groups, e.g. , and optionally substituted norbornene. In some such embodiments, the polymer The azide groups of the first surface are reacted with the norbornene groups of the second surface to form a grafted polymer. In some other embodiments, the first plurality of functional groups includes glycidyl groups. In some other embodiments, the polymer includes a Boc group or an epoxy group. deprotecting the protected amino groups; and connecting the amino groups of the polymer to the glycidyl ether groups or covalently attaching the grafted polymer to the first surface by reacting with the epoxy groups. .
[0158] Some embodiments described herein include a first surface having a first plurality of functional groups covalently attached thereto. providing a substrate having a structure in which the polymerizable compound is a polymerizable compound having a structure represented by formula (I) and formula (II) as described herein; providing a polymer having a repeat unit of formula (IV), or formula (V); A first plurality of functional groups on the first surface are reacted with the polymer, thereby forming the polymer into a pre-coated polymer. and covalently attaching the polymer described herein to the first surface of the substrate. In some such embodiments, the process or method comprises attaching the first surface of the The process or method further comprises providing a functionalized oligonucleotide comprising one or more functionalizing moieties. reacting said one or more functionalizing moieties with said polymer; and covalently attaching the functionalized oligonucleotide to the polymer. In some such embodiments, the first plurality of functional groups on the first surface includes vinyl, acryloyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkynyl, Cycloalkynyl, heterocycloalkynyl, nitrene, aldehyde, hydrazinyl, glyoxylate Lysyl ether, epoxy, carbene, isocyanate, maleimide, optionally substituted or a combination thereof, or The multiple functional groups are vinyl, acryloyl, alkenyl, cycloalkenyl, heterocycloalkenyl, alkenyl, alkynyl, cycloalkynyl, heterocycloalkynyl, nitrene, a aldehydes, hydrazinyls, glycidyl ethers, epoxies, carbenes, isocyanates, maleimide, an optionally substituted variant thereof, or a combination thereof. In some such embodiments, the one or more functionalized moieties include an amino , azide, carboxyl, acid anhydride, tetrazine, epoxy, glycidyl ether, vinyl alkenyl, acryloyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aldehydes, hydrazinyls, maleimides, and optionally substituted variants thereof, or a combination thereof, or the one or more functionalized moieties include: Amino, azido, carboxyl, acid anhydride, tetrazine, epoxy, glycidyl ether , vinyl, acryloyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl aryls, nitrenes, aldehydes, hydrazinyls, maleimides, and their optionally substituted variants or a combination thereof.
[0159] In any embodiment of the method described herein, the compound of formula (I) and formula (II), formula (IV) ), or the polymer or grafted polymer having a repeating unit of formula (V) may further comprise a poly acrylamide, polyacrylate, polyurethane, polysiloxane, silicone, poly Liacrolein, polyphosphazene, polyisocyanate, polyol, and polysaccharide or a combination thereof, In some such embodiments, the polymer further comprises the structure shown below: The repeating unit of the polyacrylamide of formula (IIIa) or formula (IIIb) is may include multiple.
[0160] In any embodiment of the methods described herein, the method further comprises the step of: In some embodiments, the method includes a washing step to remove the functionalized oligonucleotides. Further, a drying step is included.
[0161] In any of the embodiments described herein, the substrate may be patterned or unpatterned. or combinations thereof from glass, silica, quartz, plastics, metals, metal oxides In one embodiment, the surface of the substrate comprises glass. In some embodiments, the surface of the substrate may include both functionalized silane coated regions and inactive regions. In some embodiments, the inactive regions include glass regions, metal regions, mask regions, and gaps. In one embodiment, the inactive region is selected from a glass Includes.
[0162] In any of the embodiments described herein, the QC marker is a polymer and / or a poly It may be included in a mer structure.
[0163] In any of the embodiments described herein, the polymer or grafted polymer may be prepared by any method known in the art. Various surface application techniques known in the art, such as spin coating, spray coating, immersion It can be applied to the surface of the substrate via dip coating, inkjet coating, etc. can.
[0164] Substrate Material and Design In some embodiments, the substrates used in this application include glass, fused silica, and other silicon. In some embodiments, the silica-based substrate may also include a silica-containing material. , silicon, silicon dioxide, silicon nitride, silicon hydride. The substrates used in this application include polyethylene, polystyrene, poly(vinyl chloride), poly Polypropylene, nylon, polyester, polycarbonate, and poly(methyl methacrylate) Suitable plastic materials include poly(methyl ether). methacrylate), polystyrene, and cyclic olefin polymer substrates. In some embodiments, the substrate is a silica-based material or a plastic material. In one embodiment, the substrate comprises at least one surface comprising glass.
[0165] In some embodiments, the substrate may be or may include a metal. In some embodiments, the metal is gold. The surface comprises an oxide. In one embodiment, the surface comprises tantalum oxide or tin oxide. .
[0166] Acrylamides, enones, or acrylates can also be utilized as substrate materials. Other substrate materials include, but are not limited to, gallium arsenide, indium phosphide, Aluminum, ceramics, polyimide, quartz, resin, polymer, and copolymer The foregoing list is illustrative of the present application and is not intended to be limiting of the present application. do not have.
[0167] In some embodiments, the substrate and / or substrate surface may be quartz. In the form, the substrate and / or substrate surface is a semiconductor, i.e., GaAs or ITO. obtain.
[0168] The substrate may comprise a single material or multiple different materials. The substrate may be a composite or laminate. The substrate may be flat, circular, textured and patterned. The patterns may be, for example, as described in U.S. Pat. No. 8,778,849, which is incorporated by reference. forming features on non-metallic surfaces, such as those described in Another useful patterned surface can be formed by metal pads that are For example, U.S. Patent Application Publication Nos. 2014 / 0243224 and 2011 / 017 No. 2118, and U.S. Pat. No. 7,622,294 (each of which is incorporated herein by reference). The surface may be provided with a well-filled surface, such as that described in In an embodiment using a patterned substrate, the gel is applied to the pattern. It is possible to selectively deposit a gel on a feature (e.g., depositing a gel on a metal pad). or the gel can be attached to the inside of the well) Alternatively, the gel can be applied uniformly to both the pattern features and the interstitial areas. It is possible.
[0169] Advantages of using plastic-based substrates in the preparation and use of molecular arrays include low cost and Preparation of suitable plastic-based substrates, for example by injection molding, is a It is generally less expensive than preparing a silicon-based substrate, for example by etching and bonding. Another advantage is that the almost unlimited variety of plastics allows fine tuning of the optical properties of the support. and be adaptable to the intended or intended use.
[0170] When metal is used as the substrate or as pads on the substrate, this is dependent on the desired application, i.e. This may be because the conductivity of metals allows for modulation of the electric field of DNA-based sensors. Thus, the immobilized oligonucleotides can enhance DNA mismatch discrimination. can affect the orientation of the DNA molecules or DNA hybridization kinetics can be accelerated.
[0171] In some embodiments, the substrate is silica-based, but depending on the application in which the application is practiced, the substrate used may be any suitable substrate. The form of the material may vary. However, generally, it will be a support such as silica, e.g., fused silica. Slides of material are particularly useful in the preparation and subsequent synthesis of molecules. Particularly useful in practice is the melt-melting agent sold under the trade name SPECTRASIL™. The silica slides are not particularly limited. Nevertheless, the present application is directed to substrates such as beads and rods. It will be apparent to those skilled in the art that the present invention is equally applicable to other representations of the present invention, including polymeric supports. cormorant.
[0172] In some embodiments, the surface of the substrate comprises a functional molecule coating region and a coating. In some embodiments, the functional molecular coating comprises both a high molecular weight and an inactive region free of the active material. The functional molecular coating region is a hydrogel coating or a polymer coating. Since the region may contain reactive sites, the region may be used to bind the molecule through chemical bonds or other molecular interactions. In some embodiments, the functional molecular coating can be Areas (e.g., reactive features, pads, beads, posts, or wells) and inactive The conductive areas (called interstitial areas) alternate to form a pattern or grid. Such patterns can be one-dimensional or two-dimensional. In this embodiment, the inactive regions may be glass regions, metal regions, mask regions, or combinations thereof. Alternatively, these materials may form reactive regions. The inertness or reactivity depends on the chemistry and processes used in the substrate. In one embodiment, the surface comprises a glass region. In another embodiment, the surface comprises a metal region. In yet another embodiment, the surface comprises a mask region. In some embodiments of the product, the substrate can be a bead. capable of being or otherwise in the compositions or methods described herein. Non-limiting exemplary substrate materials that can be used include those described in U.S. Pat. No. 8,778,848. and 8,778,849, each of which is incorporated herein by reference. INCORPORATED INTO THE SPECIFICATION.
[0173] In some embodiments, the substrate described herein forms at least a portion of a flow cell. In some such embodiments, the flow cell is further In addition, functional molecules can be attached to the surface of the substrate via a coating, such as a polymer coating. In some embodiments, the polynucleotide comprises a polynucleotide that is inserted into a flow cell. It exists in the form of a polynucleotide cluster, and the polynucleotides of the polynucleotide cluster The adsorbent is attached to the surface of the flow cell via a polymer coating. In this case, the surface of the flow cell body to which the polynucleotides are bound is considered to be the substrate. In this embodiment, a separate substrate with a polymer-coated surface is fitted into the flow cell body. In a preferred embodiment, the flow cell is divided into multiple lanes or multiple sectors. a flow chamber having a plurality of lanes or sectors, , coated with a covalently attached polymer coating as described herein. In some embodiments of the flow cells described herein, a single polynucleotide is provided. The linked polynucleotides in the tid cluster have the same or similar nucleotide sequence. In some embodiments of the flow cells described herein, different polynucleotide classes are The binding polynucleotides of the two antibodies have different or dissimilar nucleotide sequences. Examples of methods and compositions for producing flow cells that can be used in the methods and compositions described herein are given below. Suitable flow cells and substrates include, but are not limited to, those manufactured by Illumina Inc. Commercially available from San Diego, Calif., or US patent application Ser. No. 09 / 200,366, filed on Nov. 13, 2009. Publication No. 2010 / 0111768 or Publication No. 2012 / 0270305 and US Pat. No. 6,399,933, each of which is incorporated herein by reference. can be done.
[0174] Sequencing Applications The compositions, devices, or methods described herein may be used in conjunction with any of a variety of amplification techniques. Exemplary techniques that may be used include, but are not limited to: However, polymerase chain reaction (PCR), rolling circle amplification (RCA), and multiple substitution amplification (MDA) are Amplification by multiplex amplification (MDA), or random primed amplification (RPA). In this method, one or more primers used for amplification are attached to the polymer coating. In a PCR embodiment, one or both of the primers used for amplification can be It is possible to combine the primers into a primer coating. The format is that the double-stranded amplicon is composed of two binding primers flanking the copied template sequence. This is often called bridge amplification because it forms a bridge-like structure between the immers. Exemplary reagents and conditions that can be used for bridge amplification are described, for example, in U.S. Pat. 41658, U.S. Patent Application Publication No. 2002 / 0055100, U.S. Pat. No. 7,115,400, U.S. Patent Application Publication No. 2004 / 0096853, No. 2004 / 0002090, No. 2007 / 0128624, and No. 2008 / 0009420, each of which is incorporated herein by reference in its entirety. The PCR amplification can also be performed by binding to a polymer coating. It is possible to carry out the amplification using one of the amplification primers in solution and a second primer in solution. An exemplary format using a combination of one binding primer and a soluble primer is shown below. The method is described, for example, in Dressman et al., Proc. Natl. Acad. S ci.USA 100:8817-8822(2003), International Publication No. 05 / 01014 No. 5, U.S. Patent Application Publication No. 2005 / 0130173, or U.S. Patent Application Publication No. 2005 / 0 No. 064460, each of which is incorporated herein by reference. Emulsion PCR is an exemplary format. In the methods described herein, the use of emulsions is optional and, in fact, some It will be appreciated that in this embodiment, no emulsion is used. Further, the primer is , directly bound to a substrate or solid support as described in the ePCR references It is not necessary, but instead it can be bonded to the polymer coating described herein. It is Noh.
[0175] RCA techniques can be modified for use in the methods, compositions, or devices of the present disclosure. Exemplary components that can be used in an RCA reaction and how RCA is used to generate amplicons are given below. The principle of generating the β-amino acid sequence is described, for example, in Lizardi et al., Nat. Genet. 1999. :225-232(1998) and U.S. Patent Application Publication No. 2007 / 0099208 RCA The primers used can be in solution or attached to a polymer coating. It is possible.
[0176] The MDA technique may be modified for use with the methods, compositions, or devices of the present disclosure. Some basic principles and useful conditions for MDA are described, for example, in Dean et al. al.,Proc.Natl.Acad.Sci.USA 99:5261-66(20 02), Lage et al., Genome Research 13:294-3 07(2003), Walker et al., Molecular Methods for Virus Detection,Academic Press,Inc. , 1995, Walker et al., Nucl. Acids Res. 20:16 91-96 (1992), U.S. Patent No. 5,455,166 and U.S. Patent No. 5,130,238 and US Pat. No. 6,214,587, each of which is incorporated by reference. The primers used in MDA may be in solution or in a polysaccharide. It is possible to bond the marker coating to the
[0177] In certain embodiments, a combination of the above exemplified amplification techniques may be used. For example, it is possible to use a combination of RCA and MDA. Here, RCA is Concatameric primers can be prepared in solution (e.g., using solution-phase primers). The amplicons are then bound to the polymer coating. It can be used as a template for MDA using primers. In this example, RCA The amplicons generated after the combined steps of ELISA and MDA were will bind to the
[0178] In some embodiments, the functionalized hydrogel or polymer, as described herein, The substrate coated with the compound is used in a method for determining the nucleotide sequence of a polynucleotide. In such an embodiment, the method may further comprise: (a) isolating a polynucleotide sequence comprising: The polymerase may be coated with a polymer or hydrogel coating as described herein. A step of contacting a polynucleotide cluster bound to a surface of a substrate via either and (b) providing a nucleotide to the polymer-coated surface of the substrate to bind the nucleotide. As a result, when one or more nucleotides are available to a polynucleotide polymerase, (c) generating a detectable signal from one or more polynucleotide fragments. (d) repeating steps (b) and (c); By repeating the above steps, polynucleotides present in one or more polynucleotide clusters can be obtained. and determining the nucleotide sequence of the nucleic acid sequence.
[0179] Nucleic acid sequencing can be used to sequence polynucleotides by a variety of processes known in the art. It is possible to determine the nucleotide sequence of the nucleic acid sequence. The polymer coatings described herein may be prepared using a SBS process. determining the nucleotide sequence of the polynucleotide bound to the surface of the substrate via any one of In such a process, one or more nucleotides are added to a polynucleotide fragment. A template polynucleotide associated with the polymerase is provided. is a sequence that adds one or more nucleotides to a newly synthesized nucleic acid strand that is complementary to the polynucleotide template. The synthesis is carried out by incorporating a part of the template polynucleotide or A universal or non-variable nucleic acid is covalently attached to one end of the nucleic acid. riable) initiated from an oligonucleotide primer complementary to a portion of a nucleic acid When a nucleotide is incorporated into a template polynucleotide, a detectable signal is generated. This tells us which nucleotides were incorporated at each step of the sequencing process. In this way, it is possible to determine the sequence of the polynucleotide sequence of at least one of the template polynucleotides. A nucleic acid sequence complementary to at least one of the template polynucleotides can be generated. This allows determination of the nucleotide sequence of the region.
[0180] The flow cell is prepared according to the method of the present disclosure and is used for sequencing-by-synthesis (S Arrays that are subjected to the BS method or other detection techniques that require repeated delivery of reagents during cycling. For example, the first SBS cycle is started To begin the process, one or more labeled nucleotides, a DNA polymerase, etc., are added to the reaction system of the present invention. A flow cell containing a nucleic acid array prepared by the method described herein. Primer extension leads to the incorporation of a labeled nucleotide. The sites of the array that are detected can be optionally further Furthermore, once a nucleotide is added to the primer, it terminates further primer extension. For example, nucleotides having reversible terminator moieties may be provided. An analog is added to the primer, which then delivers a deblocking agent to remove the moiety. It is therefore possible to prevent further elongation from occurring until the end of the sequence. In embodiments where detection is performed, a deblocking agent may be delivered to the flow cell (before or after detection is performed). Washing can be performed between the various delivery steps. Repeating the process n times, the primer is extended by n nucleotides to generate a sequence of length n. It is easily detectable for use in arrays produced by the methods of the present disclosure. Exemplary SBS procedures, fluidics systems, and detection platforms that can be adapted include: For example, Bentley et al., Nature 456:53-59 (2008 ), International Application No. 04 / 018497, U.S. Patent No. 7,057,026, International Application No. 91 / 06678, 07 / 123744, U.S. Pat. No. 7,329,492, Specification No. 7211414, Specification No. 7315019, Specification No. 7405281 and U.S. Patent Application Publication No. 2008 / 0108082, each of which is incorporated herein by reference in its entirety.
[0181] Other sequencing methods, including those that use cyclic reactions such as pyrosequencing, are also possible. Pyrosequencing is a sequencing procedure that detects whether a specific nucleotide Detect the release of inorganic pyrophosphate (PPi) as it is incorporated into nascent nucleic acid strands (Ronag hi, et al.,Analytical Biochemistry 242(1 ), 84-9 (1996), Ronaghi, Genome Res. 11(1), 3- 11(2001), Ronaghi et al.Science 281(5375) , 363 (1998), U.S. Patent No. 6,210,891, U.S. Patent No. 6,258,568 No. 6,274,320, each of which is incorporated herein by reference in its entirety. In pyrosequencing, the released PPi is converted to ATPase It is detected by its immediate conversion to adenosine triphosphate (ATP) by phospholipase. The degree of ATP produced can be used to measure the photons produced by luciferase. Therefore, the sequencing reaction can be detected via a luminescence detection system. The excitation radiation source used in the fluorescence-based detection system is It is not necessary for the pyrosequencing procedure. Useful fluidic systems, detectors, and procedures that can be used for the application are described in, for example, International Publication No. US Patent Application Publication No. 12 / 058096, US Patent Application Publication No. 2005 / 0191698, US It is described in Japanese Patent Nos. 7595883 and 7244559. , each of which is incorporated herein by reference in its entirety.
[0182] For example, Shendure et al. Science 309:1728-173 2 (2005), U.S. Patent Nos. 5,599,675 and 5,750,341 (each of which is incorporated herein by reference in its entirety). Sequencing-by-ligation reactions, including those described herein, are also useful. For example, Bains et al., Journal of Theoretica l Biology 135(3),303-7(1988), Drmanac et al., Nature Biotechnology 16, 54-58 (1998), Fodor et al.,Science 251(4995),767-773(1 995), WO 1989 / 10977, each of which is incorporated by reference in its entirety. Sequencing-by-hybridization, as described in the above, which is incorporated herein by reference. A sequencing-by-ligation procedure and a sequencing step may be included. In both the scanning-by-hybridization procedure, the array sites The nucleic acid is subjected to repeated cycles of oligonucleotide delivery and detection. The fluidic systems for the SBS methods described in the references cited herein include sequencing- For bi-ligation or sequencing-bi-hybridization procedures The present invention can be readily adapted for delivery of a wide variety of reagents, typically oligonucleotides. is fluorescently labeled, which can be used in conjunction with SB Detection can be achieved using a fluorescence detector similar to that described for the S procedure.
[0183] Some embodiments involve methods involving real-time monitoring of DNA polymerase activity. For example, the incorporation of nucleotides can be achieved by using a fluorophore-bearing polymerase. Fluorescence resonance energy transfer (FRET) interactions between enzymes and γ-phosphate-labeled nucleotides or using zeromode waveguides (ZMWs) Techniques and reagents for FRET-based sequencing are available, for example, from For example, Levene et al. Science 299, 682-686 (2003 ), Lundquist et al.Opt.Lett.33,1026-1028( 2008), Korlach et al.Proc.Natl.Acad.Sci.U SA 105,1176-1181 (2008), and these disclosures are incorporated herein by reference. The entirety of which is incorporated herein by reference.
[0184] Some SBS embodiments include a method for the synthesis of nucleotides that are released as they are incorporated into an extension product. For example, sequencing based on the detection of emitted protons is on Torrent, Guilford, Connecticut, Life Technology ie, a subsidiary of the U.S. Patent No. 5,313,663; or Patent Application Publication No. 2009 / 0026082 and No. 2009 / 0127589 , Specification No. 2010 / 0137143, or Specification No. 2010 / 0282617 (each of which is incorporated herein by reference in its entirety). Sequencing methods and systems can be used.
[0185] Another useful application of the arrays of the present disclosure, for example produced by the methods described herein, is to Gene expression analysis is something called digital RNA sequencing. Any RNA sequencing technique can be used to detect or quantify RNA. The sequencing techniques may be performed using sequencing methodologies known in the art, such as those described above. Gene expression can also be measured by direct hybridization to the array. using hybridization techniques carried out by the hybridization or where the products are on an array It is possible to detect or quantitate using a multiplex assay that is detected. For example, arrays of the present disclosure made by the methods described herein can be used to identify one or more It is also possible to genotype genomic DNA samples from multiple individuals. Array-based expression and genotyping assays can be performed on the arrays shown. Exemplary methods for the analysis are described in U.S. Pat. Nos. 7,582,420 and 6,890,741. Specification, US Patent No. 6,913,884 Specification, US Patent No. 6,355,431 Specification, US Patent Application Publication No. 2005 / 0053980, No. 2009 / 0186349, or No. 2005 / 0181440, each of which is incorporated herein by reference in its entirety. No. 6,399,433, which is incorporated herein by reference.
[0186] In some embodiments of the above methods using a flow cell, only a single type of nucleotide is detected. In such an embodiment, the nucleotide is selected from the group consisting of dATP, dCTP, dGTP, dTTP, and analogs thereof. In another embodiment of the above method using a flow cell, multiple different types of nucleic acids can be selected. In such a method, the nucleotides are present in the flow cell during a single flow step. The peptides consist of dATP, dCTP, dGTP, dTTP, and their analogs. The compound may be selected from the group consisting of:
[0187] One or more polymeric polymers attached to a polymer coating on the surface of the substrate present in the flow cell. For a polynucleotide, the nucleotides incorporated during each flow step (nuc The determination of leotides or nucleotides is This is accomplished by detecting a signal that occurs at or near the octide template. In some embodiments of the above methods, the detectable signal comprises an optical signal. In other embodiments, the detectable signal includes a non-optical signal. In embodiments, the non-optical signal includes a signal in one or more polynucleotide templates. This includes changes in pH at or near the pH level. EXAMPLES
[0188] Additional embodiments are disclosed in more detail in the following examples, which are included in the appended claims. It is not intended to be limiting in any way.
[0189] Example 1 Scheme 1. Synthesis of orthogonally bifunctionalized polyacrylamides [ka]
[0190] Scheme 1 shows the synthesis of poly-acrylamide-co-AzAPA-co-aminoethyl acrylamides. The synthetic scheme for the preparation of L-PAmAzA is shown. In the first step, N-(5-bromoacetamidylpentyl)acrylamide (BrAPA) in DMF N-(5-azidoacetate) was obtained by reacting it with sodium azide at 35°C for 2 hours. Next, we synthesized AIBN-type polymer. Using the initiation system (Vazo56), AzAPA was reacted with acrylamide and N-(2- L-PAmAzA was synthesized by reacting it with 1,2-diaminoethyl (methacrylamide) HCl. The resulting L-PAmAzA had a molar ratio of x:y:z of about 90% to about 5%. It has three repeat units which is about 5%.
[0191] In addition, by introducing N,N'-methylenebisacrylamide monomer into the polymerization reaction, Crosslinking of L-PAmAzA was achieved by the following crosslinker having the exemplary structure shown below: A polymer (XL-PAmAzA) was formed.
[0192] [ka]
[0193] A series of linear polyacrylamides bearing orthogonal functionalities were thermally opened following a similar procedure as above. The reaction was carried out using the initiator Vazo56. The reaction time was about 1.5 to 3 hours, and then M A purification step via precipitation into eCN followed. Table 1 below lists the monomers for the polymerization reaction. Summarize the amount of.
[0194] [ka]
[0195] [Table 1]
[0196] To demonstrate the orthogonal reactivity of bifunctional polyacrylamide, five moieties were fabricated on the surface of an epoxy monolayer. Three new polyacrylamides (polymers) in Table 1 containing 10% aminoethyl functionality were 1, "P1"; polymer 4, "P4"; polymer 6, "P6") coating performance Polymer 1 and Polymer 6 were evaluated against a standard norbornene monolayer surface. The polymers L-PAmAzA and XL-PAmAzA have the structures shown below. A simplified structure is shown below:
[0197] [ka]
[0198] Standard PAZAM polymer was used as a control. The layout of the flow cell with respect to the layer surfaces is summarized in Tables 2 and 3, respectively.
[0199] [Table 2]
[0200] [Table 3]
[0201] HiSeq substrate (provided by Illumina, San Diego, CA) For this initial screening, the CVD process was carried out using a dryer. Polyacrylamide polymers were synthesized by strain-promoted azide click reaction. It reacted with norbornene via a modified azide click reaction. The resulting mixture was covalently bonded to the surface of a norbornene monolayer at 60°C. The mide polymer was subjected to an epoxy ring-opening reaction using amine functional groups to covalently attach the polymer to the surface. The method was evaluated using two QC metrics: Both QC1 and QC3 were fitted with a 450V PMT and a 555BP filter element. The mission will utilize a green laser. The TET QC oligo mix for QC1 is 1 .6mM: 100mL of 16μM oligo + 0.9mL of HT1. TET for QC3 QC oligo mix is 0.6 mM (each): 35 mL of 16 μM oligo + 0.9 μM L HT1. Norbornenesilane monolayers in TET QC1 and TET QC3 Typhoon fluorescence images of polymer-coated flow cells and the T of polymers on the surface The relevant charts of median yphoon intensity are shown in Figures 1A, 1B, 1C, and 1D. The results are shown in Table 1. Typhoon fluorescence images of polymer-coated flow cells and Typhoon of polymers The relevant charts of median n intensities are shown in Figures 2A, 2B, 2C, and 2D, respectively.
[0202] The TET QC measurements for norbornene and epoxy surfaces are shown in Tables 4 and 5, respectively. To summarize.
[0203] [Table 4]
[0204] [Table 5]
[0205] The results of the flow cell pairs described above support sequencing-by-synthesis. We provide evidence supporting the utility of orthogonal reactivity of polyacrylamide materials. All azide-functionalized materials tested were able to bind tightly to the norbornene surface. This resulted in a stable surface as measured by thermal stress testing. This means that the azide has been incorporated into the polymer structure. Second, the amine-functionalized polymer All of the epoxy surfaces were able to be coated using a drying oven. The primer concentration on the surface was about 20-30k. In these experiments, the control polymer ( Standard PAZAM (which does not have amine functionality) exhibited the greatest surface loss after thermal stress testing. This is an expected result. P4, P5, and P6 each had 5% amine functionality and showed moderate surface stability. showed that these polyacrylamide-coated surfaces are robust (Polymer After subjecting the coating surface to standard stress testing, the surface reduction was approximately 20%-30%. The results of the TET QC signal changes on the norbornene monolayer surface and the epoxy monolayer surface are shown in Figure 1. 3A and 3B, respectively. Of the three bifunctionalized polyacrylamides tested, , polymer 4 shows the best surface robustness.
[0206] The orthogonal polyacrylamides prepared by the above procedures are generally random copolymers. Separating the different functional parts of the polymer structure, e.g., removing all the azide functional groups from all the It may be desirable to separate the amine functionalities of the polymer into different segments of the polymer chain. This alternative synthesis uses controlled radical polymerization (CRP) techniques (e.g., RAFT, ATRP) Schemes 2.1 and 2.2 show the synthesis of block copolymer AE Two synthetic routes for preparing MA-b-AzAPA (polymer 7) are shown.
[0207] Scheme 2.1 [ka]
[0208] Scheme 2.2 [ka]
[0209] Block copolymer AEMA-b prepared by RAFT technique according to Scheme 2.2 The coating performance of -AzAPA was evaluated by forming a random copolymer on the surface of a single epoxy silane layer. The CVD process was carried out at 60 °C in an oven with a dryer. The flow cell was incubated overnight. The results are summarized in Table 6. The relationship between the amino functional groups of polymer 7 and polymer 4 on the epoxy surface. The coupling reaction was carried out at 60° C. for 1 hour.
[0210] [Table 6]
[0211] Two QC metrics (QC1 and QC3) were used to measure the performance of the method. Polymer coating on epoxysilane monolayer surface in QC1 and TET QC3 Correlation of Typhoon fluorescence images from a flow cell with median Typhoon intensities for polymers The charts are shown in Figures 4A, 4B, 4C, and 4D, respectively. The results of the signal change are shown in Figure 4E. The TET QC measurements for the epoxy surface are shown in the table below. Both materials have been measured using TET QC performed after thermal stress testing. In each case, the coating was very uniform and gave a stable surface. It was.
[0212] [Table 7]
[0213] Example 2 Scheme 3 [ka]
[0214] Scheme 3 shows the preparation of substrates by immobilizing DNA copolymers on silanized substrate surfaces. A flowchart of the method is shown below. First, an alkyne-functionalized primer is used to synthesize an acrylamide monomer. Reactions with monomers, azido-acrylamide monomers, and amino-acrylamide monomers By reacting the terpolymer with the glycerol to form a pre-grafted ternary copolymer (DNA copolymer), To form a NA copolymer, the substrate surface is first treated with a silane containing an epoxy group. Then, DNA copolymers were prepared by reacting the primary amino groups of the polymer with the epoxy groups of the silane. The structure of the DNA copolymer prepared by this process is similar to that of other The copolymer can be modified by the addition of monomers such as N,N-methylenebisacrylamide. Add mides to introduce crosslinks in a controlled manner, or inimers (or monomeric initiators) ) to introduce branching points in a defined manner. If necessary, functional portions of the polymer can be isolated using controlled polymerization techniques such as NMP or Block copolymer structures can also be made to be more effective.
[0215] Example 3 Scheme 4. Oligomeric reactions with tetrazine-functionalized polymers [ka]
[0216] Scheme 4 illustrates the use of bicyclo[6.1.0]nona- 4-yne ("BCN") functionalized P5 or P7 primers and tetrazine modified acrylamide This shows the reaction between the amide polymer ("Tz-Am") and the uncatalyzed strain-promoted click reaction. The reaction can be carried out at room temperature and is compatible with aqueous environments. The modified polymers can be prepared by several methods, e.g., precipitation or tangential flow filtration. The process can be carried out using a purification method such as TEF. Other non-limiting possible polymer backbones that can be used include polyacrylates. or polyphosphazenes.
[0217] Scheme 5. Attachment of pre-grafted tetrazine polymer to a surface [ka]
[0218] Scheme 5 shows the reaction of pre-grafted tetrazine acrylamide polymer with the substrate norbornene. Binding to a norbornene-functionalized surface is shown. The norbornene-silanized surface was obtained from Illumina. It is a standard component of the NextSeq® platform from TETRAZINE. The carboxyl functionalized polymer and the BCN polymer are attached to the substrate instead of forming a grafted polymer. It can be attached to the surface in situ.
[0219] To assess the feasibility of this approach, initial experiments will be carried out in small scale model systems. This was carried out in a large-scale solution reaction (Scheme 6).
[0220] Scheme 6 [ka]
[0221] Scheme 6 shows the synthesis of norbornene (Nb) and commercially available bipyridine in a 1:1 molar ratio. This shows the reaction between lysyltetrazine (BiPy). The reaction was carried out in an NMR tube at room temperature using 1000 mM NaCl. The NMR spectrum of the reaction mixture was The measurements were taken at three different times: once at the start of the reaction (t=0), once after 15 minutes, and once after 60 minutes. The NMR spectrum was taken at 100 nm. The NMR spectrum was taken at 100 nm for norbornene (with a chemical shift of about 5.8 ppm). ) disappeared and was almost invisible after 1 hour ( See Figure 5), which shows the rapid kinetics of the reaction between tetrazine and norbornene.
[0222] Scheme 7 [ka]
[0223] In another experiment, Scheme 7 shows the synthesis of bisphenyl-substituted 1,2,4,5-tetrazines (1 We show a facile strain-promoted [4+2] cycloaddition of cyclooctyne (10 mM) with The reaction was carried out in dry MeOH at room temperature. Figure 6 shows the UV-vis of cyclooctyne. The absorbance showed a decreasing pattern, indicating that the reaction was nearly complete after only 9 minutes. . W.Chen, D.Wang, C.Dai, D.Hamelberg B.Wang, See Chem. Commun., 2012, 48, 1736-1738.
[0224] Example 4 Scheme 8. Preparation of pre-grafted poly(glycidyl methacrylate). [ka]
[0225] Scheme 8 shows the functionalization of the glycidyl ether group of poly(glycidyl methacrylate). Pre-grafting by reacting the primer with the amino group of the amino-PEG-azide The preparation of a comb-like polymer of grafted poly(glycidyl methacrylate) is shown. The polymer was synthesized by a catalyst-free, strain-promoted click reaction between the side chain azide group of the polymer and norbornene. It is possible to attach it to the surface of standard norbornene via a reaction. Commercially available aminoazides can be used, and the azide group can also be converted to other orthogonal functional groups. The substituents can be substituted with functional groups.
[0226] Example 5 Scheme 9. Preparation of pre-grafted poly(glycidyl methacrylate). [ka]
[0227] Scheme 9 shows the glycidyl group of poly(glycidyl methacrylate) as a functionalized primer. Pre-grafting by reacting the amino group of amino-PEG-Boc-amide with The preparation of grafted poly(glycidyl methacrylate) comb polymers is shown. The mer is then subjected to Boc-deprotection to generate a primary amino-functionalized side chain, which is then converted to a glycidyl or by bonding to an epoxy-functionalized surface.
[0228] Example 6 FIG. 7 shows the formation of a pre-grafted dendrimer with an outer surface to which oligonucleotides are attached. The dendrimer origin is functionalized with azide groups for direct surface attachment. Alternatively, the azide group can be attached to an alkyl group at the center point of the second dendrimer. and reacting the second dendrimer with a substrate-binding group "A". With a covered outer surface, Janus type particles are created for self-assembly.
[0229] Example 7 Orthogonal polymers with a polyphosphazene backbone can also be used in this application. Polyphosphazenes are a class of polymeric structures that can be used to construct dendronized polymers. It can serve as a linear scaffold for branching or for subsequent polymer attachment. 10.1 Cyclic hexachlorophosphatase for the construction of modified acrylamide monomers The synthetic route using the nucleus of
[0230] Scheme 10.1 [ka]
[0231] Schemes 10.2 and 10.3 show the synthesis of two polyphosphatides for subsequent polymer attachment. The synthesis of polyphosphazene scaffolds is shown. Several polyphosphazene syntheses have been reported by Qiu et al., anotechnology,18(2007)475-602 and Cheng et al. al.,Journal of Polymer Science,Part A:P Reported in Polymer Chemistry, 2013, 51, 1205-1214 There are.
[0232] Scheme 10.2. [ka]
[0233] Scheme 10.3. [ka]
[0234] Scheme 10.4 shows the preparation of a linear polydichlorophosphazene (PDCP) scaffold. Two possible routes are shown. Route 1 is an anionic controlled polymerization. Route 2 is a hexa Ring-opening reaction of chlorophosphazenes. Linear, cyclic, linear, and cyclic phosphazenes can be used, as well as the possibility of introducing bridges. , and route 1, which has potential access to crosslinked polymer structures, is preferred.
[0235] Scheme 10.4. [ka]
Claims
1. Repeating units of formula (V): 【Chemistry 1】 (In the formula, R 1d and R 2d are each independently selected from hydrogen, optionally substituted alkyl, or optionally substituted phenyl; R 3d are each hydrogen, an optionally substituted alkyl, an optionally substituted phenyl, or an optionally substituted C 7~14 aralkyl, R B is selected from azide, amino, Boc-protected amino, hydroxy, thiol, alkynyl, alkenyl, halo, epoxy, tetrazinyl, or aldehyde; L 4 is independently selected from an optionally substituted alkylene linker or an optionally substituted heteroalkylene linker; L 5 teeth, 【Chemistry 2】 where n is an integer from 1 to 50. Including, Repeating units of formula (VIa): 【Chemistry 3】 (In the formula, R 1e and R 2e are each independently selected from hydrogen, optionally substituted alkyl, or optionally substituted phenyl; and / or Repeating units of formula (VIb): 【Chemistry 4】 (In the formula, R 1f and R 2f are each independently selected from hydrogen, optionally substituted alkyl, or optionally substituted phenyl.
2. A polymer for functionalizing the surface of a substrate having epoxy or norbornene groups, further comprising:
2. R 1d The polymer of claim 1 , wherein is selected from hydrogen or alkyl.
3. R 2d and R 3d and n is an integer from 1 to 3. The polymer of claim 1 or 2, wherein each of
4. R B The polymer of any one of claims 1 to 3, wherein is selected from azide, amino, or Boc-protected amino, or a combination thereof.
5. L 4 The polymer of claim 1 , wherein:
6. The repeating unit of formula (V) may be represented by formula (Va) or formula (Vb), or both: 【Chemistry 5】 (In the formula, R 1d are each independently selected from hydrogen or methyl. The polymer according to any one of claims 1 to 5, represented by:
7. The polymer of claim 1 or 6, wherein n is 3.
8. R 1e and R 1f The polymer of any one of claims 1 to 7, wherein each is selected from hydrogen or alkyl.
9. R 2e and R 2f The polymer of any one of claims 1 to 8, wherein each of is hydrogen.
10. R of the repeating unit of formula (V) of the polymer according to any one of claims 1 to 5 B having a first surface to which is covalently bonded, R B is an azide or an amino substrate.
11. The covalent bond between the polymer and the first surface is R of the repeating unit of formula (V) of the polymer B When is an azide, the structural moiety 【Chemistry 6】 or any combination thereof, or R of the repeating unit of formula (V) of the polymer B is amino, the structural moiety 【Chemistry 7】 or a combination thereof, wherein * indicates the point of attachment of the polymer to the first surface of the substrate, and the HN group is derived from the amino of the repeat unit of formula (V), The polymer comprises a repeating unit of formula (V) having the structure 【Chemistry 8】 【Chemistry 9】 and attached to the first surface as The substrate of claim 10.
12. R of the repeating unit of formula (V) of the polymer B further comprising a functionalized oligonucleotide covalently attached to R B is amino, The covalent bond between the functionalized oligonucleotide and the polymer may be a structural moiety 【Chemistry 10】 or combinations thereof, wherein * indicates the point of attachment of the polymer to the functionalized oligonucleotide and the HN group is derived from the amino of a repeat unit of formula (V): The polymer comprises a repeating unit of formula (V) having the structure 【Chemistry 11】 and attached to the functionalized oligonucleotide as The substrate according to claim 10 or 11.
Citation Information
Patent Citations
Swelling surface modified contact lens produced from hydrophobic polymer containing oxylane
JP1988163812A
Aminopolyl type resin and its production
JP1997059315A
Highly volumetric method for separating, purifying, concentrating, fixing and synthesizing compound, and use based on the same
JP2009148276A
